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ABSTRACT 
 
During muscle regeneration, muscle progenitor cells are exposed to 
environmental cues that coordinate their activation, proliferation, and 
differentiation. These cues generate a genotoxic rich environment, by 
stimulating DNA synthesis and increasing the intracellular oxidation, as we here 
describe in vivo during muscle regeneration.  
Our lab has previously identified a DNA damage-activated differentiation 
checkpoint that inhibits the differentiation program in muscle progenitors 
exposed to genotoxic drugs. The differentiation checkpoint is achieved through 
the tyrosine phosphorylation of the master gene of muscle differentiation, 
MyoD, by DNA damage-activated c-Abl kinase.  
Here we show that MyoD phosphorylayion by c-Abl is associated to the 
formation of a complex containing dna repair proteins rather than transcriptional 
coactivators.  
We demonstrate that the cAbl consensus site discriminates MyoD from the 
functional paralog Myf5 and from other muscle bHLH proteins, suggesting a 
specific role for MyoD in maintenance genome integrity in undifferentiated 
muscle precursor cells. Importantly we show that upon genotoxic treatment 
MyoD is recruited to muscle specific promoters under proliferative conditions, 
depending on c-Abl phosphorylation. Of note DNA damage-dependent MyoD 
activation is required for DNA damage responsive proteins recruitment instead 
of transcription activation. Finally we show that cAbl dependent MyoD 
phosphorylation is required for cell survival and DNA-repair upon genotoxic 
insults.  
These results identify a novel transcription factor-mediated, tissue-specific, 
DNA repair mechanism. Further investigations would reveal the 
pathophysiological significance of this novel MyoD-associated function, such as 
novel mechanism that regulate satellite cell number and activity and can be 
implicated in the maintenance of the integrity of muscle regeneration in adult 
organisms. 
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SINTESI 
Durante la rigenerazione muscolare, le cellule progenitrici sono esposte ad una 
serie di stimoli extracellulari che coordinano la loro attivazione, proliferazione e 
differenziamento. Al tempo stesso, tuttavia, l’ambiente rigenerativo, stimolando 
la sintesi del DNA e aumentando lo stato di ossidazione intracellulare, costituisce 
una fonte di stress genotossico, come mostriamo in vivo in questo lavoro.  
Uno studio svolto in precedenza nel nostro laboratorio ha identificato e 
caratterizzato il checkpoint differenziativo, un processo che blocca il 
differenziamento in progenitori muscolari sottoposti a trattamenti genotossici. A 
livello molecolare il checkpoint differenziativo si realizza attraverso la 
fosforilazione da parte della kinasi attivata da danno al DNA c-Abl, di MyoD, il 
gene cardine del differenziamento muscolare.  
In questo lavoro dimostriamo che la fosforilazione di MyoD da parte di c-Abl e’ 
associata alla formazione di un complesso multiproteico contenente proteine 
coinvolte nel riparo del DNA piuttosto che co-attivatori trascrizionali. 
Dimostriamo infatti che la sequenza riconosciuta da c-Abl, e la conseguente 
fosforilazione dopo danno, distingue MyoD dal gene paralogo Myf5 e dagli altri 
fattori di trascrizione muscolari, suggerendo un ruolo peculiare per MyoD nel 
mantenimento dell’integrita’ genomica in precursori muscolari. Gli esperimenti 
presenti nel lavoro dimostrano che, dopo danno al DNA, MyoD e’ reclutato sui 
promotori dei geni muscolo specifici, in maniera dipendente da c-Abl. Inoltre 
dopo danno al DNA MyoD recluta proteine coinvolte nel riparo, piuttosto che 
nella trascrizione. Dimostriamo infine che la fosforilazione di MyoD da parte di 
c-Abl e’ necessaria, in seguito a danno al DNA, per la sopravvivenza cellulare e 
per il riparo.  
Questi risultati identificano un nuovo meccanismo di riparo del DNA, mediato 
da un fattore di trascrizione tessuto specifico. Ulteriori studi potranno rivelare 
importanti risvolti in campo medico, come un possibile coinvolgimento del 
fenomeno descritto nella mantenimento del numero e dell’efficienza di 
progenitori muscolari nel corso della vita.  
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INTRODUCTION 
 
DNA DAMAGE RESPONSE 
 
DNA damage response pathways 
 
The maintenance of the genome and its accurate replication are prerequisites for 
life. Damage to DNA arises from both environmental and endogenous sources, 
including genotoxic chemicals and radiation, reactive oxygen species and the 
intrinsic instability of the DNA molecule (Hanawalt and Spivak, 2008). 
Naturally occurring non-canonical DNA structures can also interfere with both 
replication and transcription, giving rise to gross chromosomal aberrations and 
mutations (Hanawalt and Spivak, 2008).  
An inefficient repair of DNA lesions could lead to detrimental consequences for 
the whole organism, such as cancer predisposition and premature aging. 
Connections between genome instability, cancer and senescence have been 
largely investigated in the past 10 years. Thus, given the importance of 
maintaining genome stability and of ensuring genome integrity to the progenies, 
cells have evolutionary evolved highly efficient responses to deal with DNA 
damage and to mediate DNA repair. 
To properly protect the genome, all types of DNA structural alterations must be 
detected, including nicks, gaps, double-strand breaks and the myriad alterations 
that block DNA replication (Harper and Elledge, 2007).  
From a structural point of view the types of DNA alteration can be classified in 
base modifications (methylation, oxidation), mispairs, cross-linked nucleotides 
(intra- or inter- strands covalent links), single strand breaks, and double-strand 
breaks. Different types of repair mechanisms fix different types of damage. 
 
Base modifications repair: base modification is one of the most frequent 
alterations in DNA, due to methylating and oxidating agents. Devoted repair 
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enzymes fix these common damages very efficiently, however new or unusual 
types of damage don’t get repaired (Tubbs et al., 2007).  
An example is the DNA repair performed by O6-methylguanine-DNA 
methyltransferase (MGMT), which protects the cellular genome from the 
mutagenic actions of endogenous carcinogens and clinically active alkylating 
agents (Mitra and Kaina, 1993; Pegg, 2000).  
MGMT functions by a stoichiometric and suicidal reaction mechanism in which 
the alkyl groups bound to the O6 position of guanine are transferred to a 
cysteine in its active site (fig a); this reaction results in the direct restoration of 
the normal guanine structure and self-inactivation of the MGMT (Pegg, 2000).  
 
 
Fig. a: Schematic representation of MGMT mechanism of action.  
 
 
Base excision repair (BER): BER is the predominant pathway for coping with 
a broad range of small lesions resulting from oxidation, alkylation, and 
deamination, which modify individual bases without large effect on the double 
helix structure. As, in mammalian cells, this damage is estimated to account 
daily for 10(4) events per cell, the need for BER pathways is unquestionable 
(Baute and Depicker, 2008). 
In this pathway (fig b) damaged bases are removed by a glycosylase, the 
resulting apurinic/apyrimidinic (AP) sites are processed first by Ape1 AP 
endonuclease, leaving a 5’ deoxyribose phosphate; then by an AP lyase activity 
leaving a 3’-elimination product. SSBs are then filled in by a DNA polymerase, 
either with a single nucleotide or with a longer repair patch. This is then 
followed by ligation (Hoeijmakers, 2001; Kennedy and D'Andrea, 2006). 
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Fig. b: Schematic representation of BER (adapted from (Friedberg, 2001) 
 
 
Mismatch repair (MMR): MMR removes mispaired nucleotides that result 
from replication errors and is involved in the detection and repair of DNA 
adducts (Hsieh and Yamane, 2008). Initially the heterodimeric MSH complex 
recognizes the nucleotide mismatch, followed by its interaction with 
MLH1/PMS2 and MLH1/MLH3 complexes (fig c). Several proteins, such as 
Exo1 and RPA participate in the process of nucleotide excision and re-synthesis. 
PCNA (processivity factor proliferating cell nuclear antigen) seems to recruit 
MMR proteins to the vicinity of the replication fork. MMR is bidirectional and 
can work both in 3’-5’ and 5’-3’ direction (Harfe and Jinks-Robertson, 2000). 
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Fig. c: Schematic representation of MMR (Friedberg, 2001) 
 
 
Nucleotide excision repair (NER): NER acts on a variety of helix distorting 
DNA lesions, caused mostly by exogenous sources that interfere with normal 
base pairing. A major function of NER appears to be the removal of damage, for 
example pyrimidine dimers that are induced by UV. Eukaryotic NER includes 
two major branches, transcription coupled repair (TCR) and global genome 
repair (GGR). GGR is a slow random process of inspecting the entire genome 
for damage, while TCR is highly specific and efficient and repairs DNA damage 
that blocks the progression of RNA polymerase II (for a complete review see 
Hanawalt and Spivak, 2008). The two repair systems differ from the first part of 
the pathway, having different proteins involved in the lesion recognition (fig d). 
Indeed in GGR DNA lesion is recognized by DDB2 (DNA damage-binding-2), 
the product of XPE (xeroderma pigmentosum complementation group E), which 
forms a heterodimer with DDB1 (DNA damage-binding-1) to constitute the 
DDB complex and or XPC (xeroderma pigmentosum complemetation group C) 
in complex with RAD23B and CEN2 (centrin-2). In TCR the pathway is 
initiated by the arrest of a translocating RNAP (RNA polimerase). CSB 
(Cockayne syndrome B), which is also a member of the SNF2 family of DNA-
dependent ATPases, interacts loosely with the elongating RNAPII and simulates 
transcription but becomes more tightly bound following transcription arrest (van 
Gool et al., 1997). After lesion recognition the two pathways converge 
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(Bowman et al., 1997). Transcription factor TFIIH is recruited, along with XPG 
(xeroderma pigmentosum complemetation group C), which stabilizes TFIIH. 
Helicase and ATPase activities of TFIIH subunits XPD and XPB (xeroderma 
pigmentosum complemetation group D and B) are stimulated for further opening 
of the damaged DNA. The XPF-ERCC1 (excision repair cross complementing 
1) endonuclease complex is recruited and incises the damaged DNA strand at 
the 5’ side of the bubble, whereas XPG incises on the 3’side. RFC (Replication 
factor C) loads PCNA to accommodate DNA polymerases (DNA pol) δ, ε 
and/or κ that have been implicated in repair replication. The final ligation step 
can be carried out by ligase-I and flap endonuclease-1 or by the ligase-III–
XRCC1 complex. 
 
 
Fig. d: Schematic representation of NER pathway. See text for details. ( Adapted from 
(Hanawalt and Spivak, 2008). 
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Trans-lesions repair (TLS): the process of TLS is another mechanism to deal 
with thymidine dimers and bases with bulky chemical adducts. At a DNA 
replication fork, DNA adducts may cause a replicative polymerase to stall. Cells 
have therefore developed sophisticated mechanisms for switching off the 
replicative polymerase and switching on alternative polymerase (e.g. polymerase 
β and κ) that will replicate past certain DNA lesions with high fidelity 
(Andersen et al., 2008). 
 
 
Fig. e: Schematic representation of TLS repair pathway (Adapted from (Kunkel and Van 
Houten, 2006))  
 
 
Single strand breaks (SSB) repair: SSBs are discontinuities in one strand of 
the DNA double helix and are usually accompanied by loss of a single 
nucleotide and by damaged 5’ and/or 3’ termini at the site of the break. SSBs 
derive primarily from oxidative attack by endogenous reactive oxygen species 
(ROS) or, indirectly, during the BER or as a consequence of abortive activity of 
DNA topoisomerase 1, and if not repaired can lead to DSB formation and to cell 
death (Caldecott, 2008; Shereda et al., 2008). Direct breaks are detected by 
PARP1 (Poly (ADP-ribose)polymerase 1) binding and activation , which 
promotes rapid access by, and accumulation of, downstream repair factors. The 
repair factors restore the 3’ and 5’ termini (PNPK and APEX1), fill the DNA 
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gap (pol β, δ and ε), and finally solve the brake through a ligation step (LIG1, 3 
e 4) (Caldecott, 2008).  
 
 
Fig. f: Schematic representation of SSB repair pathway (adapted from (Caldecott, 2008)) 
 
 
Double strand breaks (DSB) repair: A DNA DBS is the most serious lesion 
that can be induced by many agents, including ionizing radiation, free radicals, 
and genotoxic chemicals. DSB are also generated during DNA replication or 
meiosis. Failure to repair DSB can lead to a number of consequences, including 
mutations, gross chromosomal rearrangements cell death, somatic mutation and 
carcinogenesis (Iijima et al., 2008). 
Double strand breaks are repaired through two different pathways: homologous 
recombination (HR) and non-homologous end joining (NHEJ) (Khanna and 
Jackson, 2001).  
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HR: HR is a process by which DSBs are repaired though the alignment of 
homologous sequence of DNA and occurs primarily during the late S to M 
phase of the cell cycle, because it depends on the existence of sister chromatids 
to provide repair templates. The pathway is initiated by the MRN complex 
(MRE11, RAD50, and NBS1 complex), which recruits ATM on the DSB site 
(Lee and Paull, 2005; Paull and Lee, 2005). The MRN complex, which 
possesses a 3’-5 exonuclease activity, exposes the 3’ ends on either side of the 
DSB, a process that may also require BRCA1. The 3’ advancing strand from the 
damaged chromosome is then bound by RPA to protect DNA from further 
resection and to prevent secondary structure formation of the SS-DNA. RPA is 
then replaced by RAD51, which mediates strand invasion and DNA synthesis 
using a sister chromatid as a template. This step requires RAD51 proteins, 
Fanconi Anemia proteins and BRCA2. Finally the recombination intermediate 
structures accompanying Holliday junctions is processed and resolved by some 
helycases (BLM, WRN, etc.) and nucleases (Mus81/Eme1, etc.) (Hoeijmakers, 
2001; Khanna and Jackson, 2001).  
 
NHEJ: NHEJ is principally mediated by DNA-PK (DNA-dependent protein 
kinase). DNA-PK consists of the catalytic subunit and the regulatory subunit 
(the Ku80/Ku70 heterodimer). The Ku70/80 heterodimer exhibits sequence-
independent affinity for double-strand termini and on binding to DNA ends 
recruits and activates the DNA-PK catalytic subunit (Dvir et al., 1992; Falck et 
al., 2005; Gottlieb and Jackson, 1993). Additional proteins are required for the 
completion of NHEJ, including the artemis protein and DNA ligase IV. NHEJ is 
an error-prone repair pathway, since the process does not use a complementary 
template and consequently the fusion of the blunt ended DNA duplexes may 
result in deletion or insertion of base pairs (Lieber, 2008). 
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Fig. g: Schematic representation of DSB repair pathway, comprising both HR (A) and NHEJ 
(B). Adapted from (Weterings and Chen, 2008) 
 
 
The repair pathways just described have different importance, depending on the 
cell type or the cell-cycle phase. For instance, rapidly proliferating cells with a 
high S-phase fraction are more likely to employ HR repair, whereas cells in the 
G1 phase repair DSBs mainly by NHEJ. A combination of NER, HR, and TLS 
pathways is required to repair complex DNA lesions, such as DNA crosslinks 
(Cohn and D'Andrea, 2008). 
In addition to detecting different types of DNA lesions, cells must also be able 
to recognize very low levels of DNA damage anywhere in the genome (Rouse 
and Jackson, 2002). Elegant studies in budding yeast have demonstrated that 
even a single persistent DSB can be detected and, eventually, can trigger a 
global DNA damage response (Lee et al., 1998). 
The global DNA damage response is achieved through an amplification cascade 
that involves DNA damage sensors, tranducers and effectors. The amplification 
is due to phosphorylation cascades and adaptor proteins, which concentrate 
activated proteins and allow a strong and rapid transmission of the signal. The 
global DNA damage response is aimed to avoid the DNA damage propagation 
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before the repair pathway have completely solved DNA lesions. The principal 
events induced by the DNA damage response are therefore the cell cycle arrest 
at specific checkpoint, or apoptoss and senescence when the damage is too 
extended (Bartek and Lukas, 2003). 
The principal family of sensors in mammalian cells is the PI-3K-like kinase 
(PIKKs) family, comprising ATM, ATR and DNA-PK (Bartek and Lukas, 
2003). 
Recruitment of DNA damage- associated PIKKs to DNA lesions is thought to be 
a principal step in their activation and in their function in checkpoint signalling 
and DNA repair. Although these PIKKs have an affinity for DNA, recruitment 
to DNA lesions is facilitated by specific partner proteins, which are ATRIP for 
ATR, Ku70-Ku80 heterodimer for DNA-PK and the MRN complex for ATM 
(Falck et al., 2005). The binding between ATM, ATR and DNA-PK to their 
partners is crucial for their proper activation and consequently for the induction 
of DNA repair. The fact that these binding motifs are evolutionary highly 
conserved and functionally related (Falck et al., 2005), underline the importance 
of these mechanisms.  
The best-known pathway is the ATM activation at DSBs. Cellular responses to a 
DSB are initiated by the cooperation of ATM and NBS1 (Nijmegen breakage 
syndrome 1). Following the recognition of DNA damage by sensor proteins, 
mediators such as BRCA1, MDC1, and 53BP1 acquire post-translational 
modifications that are generated by the sensor proteins. These modified 
mediator proteins then amplify the DNA damage signal, and transduce the 
signals to downstream effectors such as RAD51, Artemis, Chk2, and p53, which 
operate during cellular enzymatic response (Iijima et al., 2008; Lavin, 2008). 
ATM activation is one of the first events occurring at DSB sites. The first model 
of ATM activation reported ATM forming an inactive dimer in cells without 
DSBs. When DSBs are generated, ATM undergoes intermolecular 
phosphorylation at its serine-1981, and this phosphorylation causes dissociation 
of ATM dimers and release of active ATM monomers (Bakkenist and Kastan, 
2003). A recent report has identified novel auto-phosphorylation sites (the 
serine-367 and the serine-1893 residues) in ATM, demonstrating that the 
phosphorylation of all these three sites is required for normal activity of the 
ATM kinase (Kozlov et al., 2006). 
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In addition to the phosphorylation process, dephosphorylation of ATM by PP2A 
(protein phosphatase 2A), PP5 (protein phosphatase 5), and Wip1 (wild-type 
p53 induced phosphatase 1) is also involved in the regulation of ATM activity 
(Lavin, 2008). Acetylation of ATM, which is dependent on Tip60 (HIV-1 Tat 
interacting protein 60 kDa), is also required for the efficient enzymatic 
activation of ATM. Tip60 acetylates several damage-related protein such as p53 
and H2AX. Enhancement of Tip60’s HAT activity in response to DSBs and 
accumulation of Tip60 at DSB sites depend on the association between Tip60 
and ATM but do not depend on the kinase activity of ATM (Lavin, 2008). 
Quite recently Berkovich E. et al. demonstated that NBS1, in complex with 
MRE11 and RAD50 (MRN complex), is required for recruiting ATM to a DSB 
site, and for efficient phosphorylation of ATM substrates (Berkovich et al., 
2007). MRN complexes thus enhance the ATM activation process and the 
amplification of signal working as docks that increase concentration of DNA 
damage response key proteins at DSB site. This event contributes to cell cycle 
checkpoint activation, suppression of chromosomal aberration, chromatin 
restructuring and DNA repair. 
Also Ku70/80 and DNA-PK are recruited at the DSB site in order to tether the 
both DSB ends together. DNA-PK is activated through its interaction with the 
Ku70/80 heterodimer and through its association with the DSB ends (Falck et 
al., 2005). The activate DNA-PK can then facilitate the recruitment of other 
repair factors to the DSB site to finally mediate the repair of the DSB 
(Weterings and Chen, 2007; Weterings and Chen, 2008).  
Although ATM principally trigger DNA repair through HR and DNA-PK 
through NHEJ, also ATM and Nbs1 function in NHEJ pathway through the 
phosphorylation of Artemis (Riballo et al., 2004). 
ATR responds to many types of DNA damage and replication stress including 
breaks, crosslinks and DNA adducts (Cimprich and Cortez, 2008; Mordes and 
Cortez, 2008). ATR senses abnormally long-stretches of single-stranded DNA 
that arise from the functional uncoupling of helicase and polymerase activities at 
replication forks of from the processing of DNA lesions such as the resection of 
double-strand breaks (Harper and Elledge, 2007). ATR forms a stable complex 
with ATRIP (ATR-interacting protein), which regulates the localization of ATR 
to sites of replication stress and DNA damage and is essential for ATR 
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signalling (Falck et al., 2005). Activation of ATR also requires the activator 
protein TopBP1, which has dual roles in the initiation of DNA replication and 
the DNA damage response. Localization of TopBP1 to sites of replication stress 
and DNA damage occurs independently of ATR through its interaction with the 
PCNA-like DNA clamp called 9-1-1 (Rar9, Rad1, Hus1) complex. TopBP1 
directly stimulates the kinase activity of the ATR-ATRIP complex towards 
multiple substrates (Cimprich and Cortez, 2008; Mordes and Cortez, 2008).  
Although ATM and ATR are typically activated by different damage and 
phosphorylate different substrate, several findings provide insight into the 
interplay between these PIKK damage response pathways. Indeed after IR in 
S/G2, activation of MNR complex by an ATM and CDK-dependent process 
creates single-stranded regions of DNA, which subsequently activate ATR 
(Jazayeri et al., 2006; Myers and Cortez, 2006). Moreover it has been 
demonstrated a reverse situation in which ATR functions upstream of ATM 
after UV treatment or replication fork stalling. In this situation ATR can 
phosphorylate and activate ATM (Stiff et al., 2006). 
It seems therefore that cells, although having preferential pathway to respond to 
specific DNA lesions, can activate several pathways together to coordinate 
cellular response to DNA damage to mediate repair and avoid the propagation of 
lesions.  
 
DNA damage and chromatin  
DNA repair pathways have to deal with DNA packaged into nucleosomes, 
which fold the genome into highly condensed chromatin. Consequently, DNA 
repair mechanisms, like other DNA-based processes, have to overcome this 
natural barrier that restrict access to their substrate (Morrison and Shen, 2005; 
van Attikum and Gasser, 2005a; van Attikum and Gasser, 2005b). Studies on 
transcription have shown that this can be achieved by posttranslational 
modification of histone tail residue (phosphorylation, acetylation, methylation or 
ubiquitination) (Kouzarides, 2007). These modifications reduce the affinity of 
histone tails for adjacent nucleosomes, thereby affecting chromatin structure. 
Moreover, the most profound effect of histone modifications is the attraction of 
specific proteins to a stretch of chromatin that has been appropriately modified 
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(de la Serna et al., 2006; Taverna et al., 2007). In the past few years has been 
clearly demonstrated that the same mechanisms occurring during transcription 
are also involved in DNA damage repair.  
A clear prove of this was shown using an in vitro NER assay demonstrating that 
chromatinized templates are repaired more slowly than nacked DNA (Gong et 
al., 2005). Furthermore nucleosome-remodeling complexes, such as the 
SWI/SNF complex, that can reposition nucleosome in an ATP-dependent 
mechanism, accelerate NER in vitro (Gong et al., 2005). 
One of the first events after DNA damage pathways activation is the 
phosphorylation of H2AX, a H2A variant, at ser139 (H2AX phosphorylated in 
ser139 is called γ-H2AX) (Rogakou et al., 1998). γ-H2AX accumulates adjacent 
to, but not directly at, the break site (Berkovich et al., 2007). In principle, all 
three major PIKK members, ATM, ATR and DNA-PK, have the potential of 
phosphorylating H2AX (Kinner et al., 2008; Paull et al., 2000), and there is 
evidence that each of them actually carries out this phosphorylation when others 
are genetically compromised (Andegeko et al., 2001; Burma et al., 2001; Limoli 
et al., 2002; Stiff et al., 2004; Wang et al., 2005; Ward and Chen, 2001), 
although ATM seems the best suited for H2AX phosphorylation. Besides being 
an ATM substrate, γ-H2AX is also a dock for ATM, recruiting it to the 
chromatin. This is the resason why, although NBS1 is localized at the DSB site, 
ATM is detected in a broad region flanking the DSB site, in addition to 
accumulating directly at the DSB site, reflecting the localization of γ-H2AX 
(Berkovich et al., 2007). γ-H2AX is critical for the repair of DNA lesions in 
mice, as H2AX deficiency results in genomic instability and cancer 
predisposition (Bassing and Alt, 2004; Bassing et al., 2003; Celeste et al., 2003; 
Celeste et al., 2002). It seems therefore to function as a dock for sensors and 
transducers of the DNA damage pathways, but also for chromating remodelling 
complexes. In yeast, several reports showed the recruitment of subunits of the 
INO80 remodelling complex to a unique DSB induced by the HO endonuclease 
at the MAT (mating-type) locus, through a direct binding to γ-H2AX (Bird et 
al., 2002; Downs et al., 2004; Morrison et al., 2004; van Attikum et al., 2004). In 
yeast also RSC, a member of the SWI/SNF class of remodelers, seems to be 
implicated in DNA damage response (Bennett et al., 2001; Shim et al., 2005).  
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In mammals another chromatin-modifying complex, named TIP 60, has been 
implicated in the repair of DNA damage. TIP60 enter DNA damage response by 
acetylating several key components, such as ATM, p53 and H2AX (Lavin, 
2008), but also affecting chromatin status. TIP60 has a histone acetyltransferase, 
an ATP activity, both of them necessary for its nucleosomal histone exchange 
activity (Ikura et al., 2000). A report by Kusch et al. demonstrates that the 
Drosophila melanogaster homologue of TIP60 (dTIP60) preferentially binds to 
and aceylates nucleosomal phosphorylated H2Av, the homologue of γ-H2AX 
(Kusch et al., 2004). 
Quite recently also the SIRT1 histone deacetylase has been implicated in DNA 
damage response. SIRT1 is indeed recruited to the chromatin upon oxidative 
treatment and its inhibition impairs DNA damage repair (Oberdoerffer et al., 
2008). 
To underline the strict connection between chromatin and DNA repair it is worth 
reporting that ATM protein can be activated, albeit at low levels, in the absence 
of detectable DSBs by chromatin alterations (Bakkenist and Kastan, 2003; 
Collis et al., 2004; Difilippantonio et al., 2005; Kitagawa et al., 2004). These 
observations are consistent with a model in which chromatin structure changes 
can initiate ATM activation.  
 
Long-term effect of defects in DNA damage response proteins 
DNA repair is important not only for single cells fate, but above all for tissue 
and whole organism functionality. Important clues for the clinical effect of DNA 
damage come from the diverse phenotypes of a rapidly expanding family of rare 
human disorders associated with genetic defects in DNA repair and damage-
response systems. Disorders affecting genome maintenance fall into three 
classes: 1) conditions in which specific types of cancer are enhanced; 2) 
conditions in which many aspects of ageing are accelerated, but cancer is 
reduced; 3) conditions in which both cancer and certain aspects of ageing are 
increased (Table a). The outcome seems to be governed by the genome 
maintenance system that is affected. The notion that in none of these syndromes 
all aspects of cancer and degenerative ageing are equally enhanced is consistent 
with the idea that each genome stability pathway covers a specific subset of 
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damage and that there are no genes or processes that counteract all forms of 
DNA damage and their consequences to the same extent. 
 
 
Table a: Classification of Syndromes induced by defects in NER TCR and GGR sub-pathways. 
Adapted from (Garinis et al., 2008). 
 
 
Detailed systematic analysis of mouse mutants deficient in DNA repair 
mechanisms, compared with their littermate controls, have revealed the 
premature appearance of various symptoms of ageing indistinguishable from the 
same phenotypes normally occurring much later in life (de Boer et al., 2002; 
Hasty et al., 2003). The overall picture emerging from these mutants is that 
genetic defects in DNA repair systems that mainly prevent mutagenesis are 
generally associated with a strong predisposition to specific types of cancer, 
with only minor symptoms of degenerative ageing phenotypes such as in 
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xeroderma pigmentosum (XP) patients. On the other hand, deficiencies in repair 
and surveillance pathways that mainly protect from the cytotoxic and cytostatic 
effects of DNA damage tend to be characterized by a decrease in the incidence 
of cancer and the premature appearance of some, but not all degenerative ageing 
phenotypes, such as that of Cockayne syndrome (CS) patients.  
An informative example incorporating all aspects discussed above is the 
nucleotide excision repair (NER) pathway. Apart from a common UV 
hypersensitivity, genetic defects in each of the two sub-pathways have virtually 
opposite consequences (Garinis et al., 2008; Hanawalt and Spivak, 2008). 
Impairment of GG-NER in humans causes XP, characterized by an increase of 
more than 1000-fold in the susceptibility to sun-induced skin cancer. This is 
explained by the fact that compromised GG-NER leads to accumulation of DNA 
lesions over the entire genome and with replication, which increases the risk of 
mutations. On the other hand, genetic defects in TC-NER are associated with the 
human progeroid disorder CS or the CS-like brittle hair disorder 
trichothiodystrophy (TTD) that also harbours a partial GG-NER defect. In both 
conditions mouse models show many symptoms of premature ageing, including 
progressive neurodevelopmental delay, cachexia, kyphosis, retinal degeneration 
and deafness. Remarkably, TTD mice as well as CS and TTD patients seem to 
be protected from cancer despite their DNA-repair defect (Garinis et al., 2008; 
Wijnhoven et al., 2005). This is explained by the fact that TC-NER repairs only 
a small but vital part of the genome, namely the transcribed strand of active 
genes, when lesions actually block RNA polymerase II. As this system deals 
with only a tiny fraction of the genome, it is not crucial for preventing mutations 
and thus cancer. Yet, it is crucial for promoting cell survival after DNA damage, 
as it enables resumption of the essential process of transcription. In a TC-NER 
mutant, the balance between anti-ageing and anti-cancer genome maintenance 
responses is shifted to the latter, favouring cell death or senescence, which 
promotes ageing, while protecting from cancer. Combinations of XP and CS, 
showing both a predisposition to cancer as well as features of segmental 
premature ageing, are very rare in patients and are mimicked in the 
corresponding mouse models (Andressoo et al., 2006).  
Therefore, most defects in distinct DNA repair systems can trigger cancer, 
ageing or both, revealing a fine-tuning among genome maintenance mechanisms 
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that mainly protect from cancer, and those that predominantly prevent non-
cancer, degenerative ageing phenotypes. 
 
 
 DNA DAMAGE AND CELLULAR DIFFERENTIATION 
 
 
The studies on DNA damage responses have principally been conducted on 
proliferating cells, including primary fibroblasts and established cell lines. 
However, the great majority of cells of eukaryotic organisms are terminally 
differentiated cells that compose tissues and organs, whose correct function and 
homeostasis along the life span depends on the protection of the genomic 
integrity. Studies performed in the last few years have highlighted important 
differences between undifferentiated and terminally differentiated cells in terms 
of DNA damage response (reviewed in Simonatto et al., 2007).  
 
DNA damage response in terminally differentiated cells 
 
During terminal differentiation an extensive reprogramming of the genome 
ensures that only a selected subset of genes (differentiation-specific genes) is 
transcribed (Forcales and Puri, 2005). In particular, genes involved in cell cycle 
progression are permanently silenced, as terminally differentiated tissues enter a 
post-mitotic state. The post-mitotic nature of differentiated tissues implies that 
they might dispense with the task of maintaining the integrity of those systems 
that constantly scan the whole genome for repair of DNA lesions. In other 
words, repair systems can be attenuated at the global genome level in terminally 
differentiated cells without the deleterious outcome that such effect would have 
in proliferating cells. Supporting this conclusion, several works have 
documented an impaired NER, DSB repair and BER in differentiated cells, such 
as neurons, adipocytes, myotubes, white blood cells and skin cells (Nouspikel, 
2007; Nouspikel and Hanawalt, 2002). A comparative analysis of BER 
efficiency in undifferentiated myoblasts vs differentiated myotubes exposed to 
oxidative stress was recently carried by Narciso et al., revealing an impairment 
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of BER in myotubes that coincided with the decreased expression of BER 
effectors, DNA ligase I and XRCC1, and the destabilization of DNA ligase IIIa 
(Narciso et al., 2007). These studies also documented an accumulation of un-
repaired DNA lesions (phospho-H2AX positive nuclear foci) in myotubes, 
coincident with an impaired BER response and depletion of BER components. 
Conceivably, the optimal repair system in terminally differentiated cells appears 
TCR, which selects for repair only actively transcribed genes. As TCR of 
damaged DNA strand relies on the integrity of the non-transcribed DNA 
template, it stands to reason that the integrity of complementary DNA templates 
must be maintained by a distinct, differentiation-specific strategy of repair. 
Differentiation associated repair (DAR) has been hypothesized to repair un-
transcribed strands in differentiated cells, in order to provide a correct template 
for repair through TCR This parsimonious strategy may backfire, though, if 
some unexpected event forces cells to re-enter the cell cycle and attempt to 
replicate and transcribe a DNA crippled by lesions (Nouspikel and Hanawalt, 
2003). This might be one of the reasons for neurons loss in Alzheimer disease, 
in which it has been shown that some neurons attempt to resume cell cycle in 
response to DNA damage, but die shortly after DNA replication (Yang et al., 
2001). 
The molecular mechanism underlying changes in repair strategies during 
differentiation is largely unknown. A model has recently been suggested, at least 
for the impairment of NER upon macrophage differentiation. This model 
implies the switch of function of the enzyme E1 – an integral component of the 
ubiquitin-pathway. E1 undergoes hypo-phosphorylation in differentiated 
macrophages, an event that reduces its interaction with E2 enzyme responsible 
for the activation by ubiquitination of NER components, such as TFIIH. As a 
result, the activity of TFIIH in the GGR sub-pathway of NER is impaired, 
whereas its activity in TCR, which is apparently not regulated by ubiquitination, 
remains unaffected (Nouspikel and Hanawalt, 2006). Whether post-translational 
modifications of NER components play a general role in selecting repair 
strategies specific to terminal differentiation remains an open question.  
A number of proteins implicated in DNA damage response in proliferating cells 
are downregulated or redistributed during terminal differentiation. For instance, 
Chk1, an essential mediator of DNA damage response in proliferating cells is 
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absent in terminally differentiated tissues (Lukas et al., 2001). Likewise, 
downregulation of E2F1 and p53 was described in terminally differentiated 
myotubes, while cellular redistribution of DNA damage-activated cAbl, and 
changes in the relative expression of p73 isoforms has been reported to influence 
the response of myotubes to genotoxic agents (Belloni et al., 2006; Puri and 
Sartorelli, 2000). These changes, and possibly others, might account for the 
resistance of terminally differentiated myotubes to concentrations of some 
genotoxic agents (e.g. IR) that trigger apoptosis in undifferentiated myoblasts 
(Latella et al., 2004). However, the observation that certain agents (e.g. 
doxorubicin) restore apoptotic pathways in myotubes, suggests that terminally 
differentiated cells might retain the option to re-express key components of the 
DNA damage-activated machinery that typically operates in myoblasts. This 
hypothesis is consistent the results reported in neurons and described above 
(Yang et al., 2001).  
Assuming that in terminally differentiated cells TCR and DAR selectively 
ensure the integrity of transcribed genes, and that this is sufficient to warrant the 
overall cellular functions, it is easy to speculate that progressive accumulation of 
DNA lesions in un- transcribed could provide an explanation for the progressive 
loss of nuclei and decline of function observed in aged organs and tissues (i.e. 
sarcopenia in muscles and degeneration of neurons). Moreover it poses the 
question of how these un-repaired lesions could be tolerated by cells, given the 
relationship between genetic instability, apoptosis, senescence and malignant 
transformation.  
 
DNA damage response in differentiation-committed cells 
 
The mechanism by which differentiation-committed cells coordinate DNA 
damage repair and the global genome reprogramming toward the expression of 
selected subset of genes (differentiation-specific genes) is still a matter of 
conjecture. However, much evidence indicates that cells, which proliferate 
toward differentiation, respond to DNA damage differently from cells that 
divide to form progenies of proliferating cells. Our previous work identified the 
differentiation checkpoint, a DNA damage-activated transcriptional checkpoint 
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in differentiation-committed cells, that is superimposed to the cell cycle 
checkpoint, to coordinate repair and the expression of differentiation-specific 
genes during DNA damage-induced cell cycle arrest (Puri et al., 2002). 
The first observations regarding the effects of DNA damage on the 
differentiation process were reported on cultured myoblasts. Exposure of cardiac 
and skeletal muscle cells to genotoxic agent doxorubicin suppressed the 
differentiation program (Ito et al., 1990; Kurabayashi et al., 1993; Kurabayashi 
et al., 1994). The inhibition of differentiation after DNA damage has been also 
observed in myoblasts and in adipocytes (Puri et al., 2002). Moreover, 
constitutive expression of viral oncogenes or cellular proto-oncogenes has been 
shown to prevent myogenic differentiation both in avian myoblasts and in 
mammalian cell lines (Alema and Tato, 1987). Oncogene-activated DNA 
replication stress and damage might account, at least in part, for the block of 
cellular differentiation. 
The molecular events underlying DNA damage responses in differentiation-
committed cells have been the object of investigation only recently. These 
studies have led to the discovery of the differentiation checkpoint as an 
additional filtering system that inhibits the differentiation program in precursor 
cells that have been arrested after DNA damage (Polesskaya et al., 2002; Puri et 
al., 2002). The overall speculation is that holding the transcription of 
differentiation genes before the completion of DNA repair could prevent the 
formation of differentiated cells bearing unresolved lesions that would not be 
otherwise repaired after differentiation. Transient and reversible inhibition of 
tissue-specific transcription factors by DNA damage-activated proteins is one 
important mechanism underlying the differentiation checkpoint. For instance, in 
myoblasts the activity of the basic helix-loop-helix (bHLH) factor MyoD, 
master-gene of the differentiation program, is inhibited by DNA damage-
activated of c-Abl tyrosine kinase. cAbl-mediated phosphorylation of tyrosine 
30 in the N-terminal domain of MyoD correlates with the block of muscle-gene 
transcription in response to genotoxic agents (Puri et al., 2002). This specific 
residue is conserved in MyoD along the evolution and belongs to the FYD 
domain, which mediates the interaction with the transcriptional co-activators 
p300 and PCAF (Puri et al., 1997a; Puri et al., 1997b; Sartorelli et al., 1997). 
Rapid de-phosphorylation eventually restores MyoD-dependent transcription, 
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thereby terminating the differentiation checkpoint. Presumably, the temporal and 
spatial restriction of MyoD inactivation is critical for the correct execution of 
this checkpoint. Constitutive inactivation of MyoD is observed in 
rhabdomyosarcomas (RMSs), as consequence of duplication and deregulated 
activity of the DNA damage-activated protein ATR (Smith et al., 1998). RMSs 
are tumors displaying extremely high genetic instability; however, the precise 
relationship between genetic instability and constitutive repression of MyoD by 
ATR has not been established.  
Differences in the molecular mechanism underlying DNA damage-induced 
block of differentiation are intrinsic to the specific phase of the cell cycle in 
which the checkpoint is activated in response to different genotoxic agents. For 
instance, agents that activate a G2/M checkpoint prevent the binding of MyoD 
to DNA (Kurabayashi et al., 1994; Puri et al., 2002) presumably because of the 
inability of MyoD to access the chromatin in cells undergoing mitosis 
(Batonnet-Pichon et al., 2006). By contrast, genotoxic agents that promote a G1 
arrest of the cell cycle, which is permissive for MyoD binding to the DNA, must 
promote additional events (e.g. cAbl-mediated tyrosine phosphorylation) that 
impair the transcriptional activity of MyoD. Thus, it is likely that different 
genotoxic agents activate distinct pathways toward the activation of 
differentiation checkpoints at discrete cell cycle boundaries. Furthermore, 
genotoxic agents that inhibit muscle-specific gene expression in myoblasts fail 
to trigger the same response in myotubes (Puri et al., 2002). This evidence 
indicates that only myoblasts are equipped with differentiation checkpoint 
machinery, and emphasizes once again the differences in DNA damage 
responses between undifferentiated tissue progenitors and their differentiated 
counterpart. 
Other works suggest that DNA damage can affect cellular differentiation. An 
example is constituted by pancreatic differentiation. One of the major players in 
pancreatic differentiation is the homeobox PDX-1. It has been demonstrated that 
PDX-1 associates to ku70 and ku80, the regulatory regions of DNA-PK. In 
response to radiation, DNA-PK is activated and in turn phosphorylates PDX-1 
leading to proteasome-dependent degradation. In correlation to PDX-1 
degradation it is observed a reduction of the insulin promoter and a decrease in 
PDX-1 mediated gene expression (i.e. glut2 and glucokinase), two markers of 
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pancreatic differentiation (Lebrun et al., 2005). A similar mechanism might be 
envisioned in other cell types, since ku70 and ku80 of DNA-PK physically 
interact with several homeodomain proteins, such as HOXC4, Oct-1 and -2 and 
Dlx-2 (Schild-Poulter et al., 2001).  
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MUSCLE AS A MODEL OF TERMINAL DIFFERENTIATION 
 
 
Skeletal muscle formation in vertebrates constitutes an excellent system to study 
the signals and the molecular mechanism that govern cellular differentiation. 
During both embryonic development and adult myogenesis (e.g. muscle 
regeneration) a population of muscle progenitors, embryonic or fetal myoblasts 
and satellite cells, respectively, differentiate into mature myofibers. Recent 
studies have revealed striking similarities in the mechanisms and the mediators 
of skeletal myogenesis in the embryo and in adult life. The epigenetic 
modifications that orchestrate the pattern of gene expression underlying the 
acquisition and the maintenance of the myogenic lineage, as well as the 
transition from muscle precursors to myofibers, have only recently become the 
object of investigation. Deciphering the network of signal that regulate these 
modifications holds the promise of revealing the targets for novel interventions 
toward boosting regeneration of skeletal muscles and, by analogy, possibly other 
tissues (Palacios and Puri, 2006). 
 
Muscle development and differentiation 
 
The vertebrate skeletal musculature is a complex organ system, composed of 
functionally discrete units that are generated by a series of distinct 
morphogenetic events during embryogenesis. All vertebrate skeletal muscles 
(apart from head muscles) derive from mesodermal precursors originating from 
the nascent somites, compartments of the paraxial mesoderm that form in a 
rostral-caudal progression during early development of all vertebrate embryos 
(Asakura and Rudnicki, 2002; Bryson-Richardson and Currie, 2008). The centre 
of myogenesis is the dermomyotome, which forms as an epithelium from the 
dorsal aspect of the early somite. The dermomyotome is nominally divided into 
epaxial and hypaxial domains that relate to the nature of innervation of distinct 
muscle populations deriving from these regions. Regulatory processes that are 
distinct from those that govern axial muscle formation control the limb and 
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cranial muscles (Asakura and Rudnicki, 2002; Bryson-Richardson and Currie, 
2008). 
Activation of myogenesis in different regions of the embryo is controlled by a 
series of complex transcriptional regulatory networks that ultimately result in the 
expression of members of the basic helix-loop-helix domain-containing 
myogenic regulatory factors (MRFs), which include myogenic factor 5 (Myf5), 
myogenic differentiation 1 (Myod1, also known as MyoD), Myf6 (also known as 
Mrf4) and myogenin (Myog) within nascent and differentiating myoblasts. 
MRFs are responsible, in concert with a myriad of cofactors, for directing the 
expression of genes that are required to generate the contractile properties of a 
mature skeletal-muscle cell. These genes act downstream of, or in parallel with, 
the paired domain and homeobox-containing transcription factors paired box 
gene 3 (Pax3) and 7 (Pax7) in different phases of myogenesis in the embryo and 
adult (Bryson-Richardson and Currie, 2008).  
The exact genetic hierarchy of the MRF genes in directing muscle 
differentiation has been a controversial subject of study in the field of 
myogenesis.  
Nearly 20 years ago, subtractive hybridization experiments were performed to 
identify and isolate myoblast-specific transcripts that were capable of 
orchestrating myogenic conversion of 10T1/2 fibroblasts. This work led to the 
identification of a single cDNA, named MyoD, which was capable of converting 
a variety of cell types (e.g., fibroblasts, chondrocytes, neurons, amniocytes) to 
myoblasts (Choi et al., 1990; Lassar et al., 1986). Soon after the discovery of 
MyoD, the three other closely related MRFs were identified (Myf5, Mrf4, 
myogenin) (Weintraub et al., 1991). 
Forced expression of MRF proteins in non-muscle cells in culture can induce 
myogenic differentiation, albeit with varying efficiency.  
In vivo, however, the distinct yet overlapping roles played by the four MRFs 
appear more evident; these roles can be partially due to differences in temporal 
expression patterns as well as protein sequence (Berkes and Tapscott, 2005). 
In the developing mouse embryo, Myf5 expression is induced in dorsal-medial 
somites (which later give rise to trunk and intercostal muscles) by signals from 
the neural tube/notochord complex and is followed by the expression of MyoD 
in the dorsal-later somites (which later give rise to body wall and limb muscles) 
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induced by signals from the dorsal ectoderm (Cossu et al., 1996; Kablar et al., 
1998). The Wnt, Sonic hedgehog (Shh) and other signalling pathways have been 
shown to contribute to muscle determination by inducing expression of Myf5 
and MyoD (Buckingham, 2001). Expression of both Myf5 and MyoD is the key 
step, which results in commitment of multipotent somite cells to the myogenic 
lineage, since disruption of both genes leads to complete absence of skeletal 
myoblasts (Rudnicki et al., 1993). Null mutations in either Myf5 or MyoD result 
in apparently normal muscle development, demonstrating a degree of genetic 
redundancy in the MyoD family. However upon careful examination, mild 
defects in trunk skeletal muscle are observed in Myf5 null embryos, whereas 
early limb and branchial arch muscle development is delayed in MyoD null 
embryos, demonstrating that these genes control early specification of epaxial 
versus hypaxial muscle lineages (Braun et al., 1992; Kablar et al., 1998; 
Rudnicki et al., 1992; Rudnicki et al., 1993). Myogenin mutants have very 
poorly developed skeletal muscle tissue even though myoblasts are present, 
suggesting that myogenin plays a critical role in terminal differentiation of 
myoblasts, but is dispensable for establishing the myogenic lineage (Hasty et al., 
1993; Nabeshima et al., 1993). Furthermore, myogenin cannot efficiently 
mediate myogenesis in the developing mouse embryo when substituted into the 
Myf5 locus, suggesting that the ability to establish the muscle lineage is not 
simply a matter of the timing of expression in the embryo, but is an inherent 
property within the protein itself (Wang and Jaenisch, 1997). 
In support of this in vivo evidence, although each of the myogenic bHLH 
proteins can initiate myogenesis when expressed in non-muscle cells in vitro, 
myogenin is not nearly as sufficient as MyoD or Myf5 in initiating the 
expression of some muscle-specific genes. The ability of Myf5 and MyoD to 
initiate previously silent muscle-specific genes has been mapped to a C-terminal 
region of MyoD, which forms a putative α-helix (Bergstrom and Tapscott, 
2001). 
The specific role played by MRF4 during myogenesis is more complex.  Initial 
studies of MRF4 knockout mice similarly suggested that, like myogenin, MRF4 
acts downstream of the redundant activities of Myf5 and MyoD (Patapoutian et 
al., 1995; Zhang et al., 1995). However, more recently it has emerged that the 
original gene targeting of the Myf5 locus resulted concomitantly in loss of 
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function of the neighbouring MRF4 gene. Restoration of MRF4 function, in 
Myf5: MyoD double knockout embryos, partially rescues embryonic 
myogenesis, suggesting that MRF4 might have some role in embryonic 
myogenesis (Kassar-Duchossoy et al., 2004). 
Taken together, all these data suggest the existence of a hierarchical model in 
which “early” MRFs activate “late” MRFs, which in turn regulate the expression 
of muscle-specific target genes. Consistently, specification of the myogenic 
lineage requires the up-regulation of MyoD and Myf5, whereas myogenin plays 
critical role in the expression of the terminal muscle phenotype previously 
established by MyoD and Myf5; MRF4 partly serves both roles.  
 
Trascriptional control of muscle differentiation 
The MRFs, together with Mef2 family proteins and other general and muscle-
specific factors, coordinate the activities of a host of co-activators and co-
repressors, resulting in tight control of gene expression during myogenesis. The 
events occurring at muscle-specific promoters have been dissected in molecular 
detail, uncovering a multitude of functional and direct interactions between 
MRFs and signaling proteins, chromatin modifying factors, and other 
transcriptional regulators (Berkes and Tapscott, 2005). 
MRFs are class II (tissue-specific) bHLH (basic helix-loop-helix) transcription 
factors and are capable of either homo-dimerization or hetero-dimerization with 
class I bHLH factors. Class I factors, which include the E proteins HEB/HTF4, 
E2-2/ITF2 and E12/E47, are ubiquitously expressed in various tissues and at 
different times during development. The basic region is required for DNA 
binding, whereas the HLH domain mediates dimerization with other bHLH 
proteins. bHLH dimers bind to paired E-box, a consensus sequence comprised 
of the sequence CANNTG. Any of the MRFs can bind the E-boxes as 
heterodimers with any of the E proteins in vitro, although preferences for 
specific sequences flanking and internal to the E-box have been determined for 
MRF homodimers and MRF/E protein heterodimers in vitro. Interestingly, 
skeletal muscle is formed in all of the knockout mouse models of the individual 
E proteins, suggesting considerable redundancy of function within the family 
(Berkes and Tapscott, 2005). 
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In vivo, each MRF efficiently binds to E boxes, which are present in the 
promoters and enhancers of muscle specific genes (Blackwell and Weintraub, 
1990; Lassar et al., 1989). 
MyoD, Myf5 and E proteins are expressed in undifferentiated myoblasts yet, in 
this cellular context, they do not activate transcription. Once extracellular cues 
are interpreted by the undifferentiated myoblasts as pro-differentiation signals, 
MyoD and Myf5 become transcriptionally competent and activate the skeletal 
myogenic program. It appears that multiple and distinct mechanisms ensure that 
transcription is not prematurely activated in undifferentiated muscle cells 
(Sartorelli and Caretti, 2005). 
A number of proteins have been identified which act as myogenic antagonists by 
directly binding to E proteins and/or MyoD family proteins, and blocking their 
ability to bind E boxes and/or activate transcription at muscle-specific 
promoters. Many of these inhibitors are themselves HLH domain proteins, and 
include Id, Twist, MyoR and Mist-1. Id comprises a family of HLH proteins 
whose expression is upregulated under high-serum conditions. A high level of Id 
protein in the cell is inhibitory for MRF activity because Id is capable of 
efficiently heterodimerizing with E proteins, sequestering them and preventing 
their interaction with the MRFs (Benezra et al., 1990). Id proteins may also 
heterodimerize with MRFs, albeit with lower efficiency. Since Id lacks the basic 
region required for DNA binding, MRF/Id heterodimers are thought to be 
devoid of transcriptional activity. A “forced” MyoDE47 dimer in which MyoD 
and E47 are contained within a single polypeptide is resistant to inhibition by Id, 
providing evidence in support of this mechanism (Neuhold and Wold, 1993). 
Similar to Id, Twist is also an HLH protein, which inhibits myogenic 
differentiation by dimerization with E proteins, sequestering them from MRFs in 
inactive complexes (Spicer et al., 1996). 
Unlike Id, Twist possesses a basic region which functions not by binding to 
DNA, but by binding to the basic region in MRFs, thus preventing the 
interaction between MRFs and their cognate E boxes in muscle-specific 
promoters (Hamamori et al., 1997). Twist is also capable of inhibiting 
myogenesis via direct interaction with Mef2 proteins (Spicer et al., 1996). In 
addition to Id and Twist, MyoR and Mist-1 are inhibitors of myogenesis. These 
factors contain basic regions and form dimers with the MRFs. MRF/MyoR and 
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MRF/Mist-1 heterodimers are competent to bind E boxes; however, these 
dimers are unable to activate transcription when bound to DNA (Lemercier et 
al., 1998; Lu et al., 1999). 
Histone deacetylases have been shown to negatively regulate expression of 
muscle-specific genes via interactions with both MyoD and Mef2 proteins. The 
class II histone deacetylases (HDAC4 and HDAC5) interact with Mef2 proteins 
and repress activation of transcription from promoters containing Mef2 sites 
(Dressel et al., 2001; McKinsey et al., 2000; McKinsey et al., 2001; Puri et al., 
2001). The class II HDACs can also inhibit MyoD-mediated transcription, but 
only in promoters containing a Mef2 site in addition to an E box, suggesting that 
this inhibition is mediated indirectly through Mef2 (Lu et al., 1999). The class I 
histone deacetylase HDAC1 associates directly with MyoD, is capable of 
deacetylating MyoD in vitro and inhibits the ability of PCAF to enhance MyoD-
dependent transcription in cell culture experiments (Mal et al., 2001). 
Furthermore, MyoD is found in a complex with HDAC1 in undifferentiated 
myoblasts, but not in differentiating myotubes (Mal et al., 2001). MyoD also 
interacts with the nuclear receptor co-repressor/silencing mediator of retinoic 
acid and thyroid hormone receptor (NCoR/ SMRT), which has been shown to 
recuit HDAC1 to target promoters (Bailey et al., 1999). 
In cell extracts derived from undifferentiated myoblasts, also Sir2 (silent 
information regulator 2; the mouse homolog of human SIRT1) is found in a 
protein complex containing the acetyltransferase pCAF (p300/ CBP-associated 
factor) and MyoD. This protein complex might associate with the chromatin of 
selected muscle gene enhancer and/or promoters that are bound by MyoD in 
undifferentiated myoblasts (Fulco et al., 2003).  
An additional inhibitory complex found at muscle gene regulatory regions 
contains the Polycomb group protein Enhancer of zeste 2 (Ezh2), a histone 
lysine methyltransferase (HKMT) that promotes transcriptional repression. 
Overexpression of Ezh2 in either established or primary skeletal muscle cells 
contrasts muscle gene expression and cell differentiation, a phenomenon that is 
dependent on the HKMT activity of Ezh2 (Caretti et al., 2004). A protein 
complex comprising the transcription regulator YY1, Ezh2 and HDAC1 can be 
detected on heterochromatin of selected muscle gene regulatory regions when 
their correspondent genes are inactive and lysine 27 of histone H3 (H3K27) is 
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hypermethylated. Chromatin engagement of Ezh2 relies on YY1, because 
reducing the levels of YY1 by RNA interference results in a lack of Ezh2 
recruitment.  
Upon differentiation induction several changes occur in the nucleus, affecting 
MyoD transcriptional activity, leading to formation of transcriptional active 
complexes. 
CDO (cAMP response element decoy oligo-nucleotide), a cell surface receptor 
of the Ig superfamily that is expressed in muscle precursor cells and other cell 
types, favors muscle differentiation, increasing phosphorylation of the E 
proteins and enhances formation of MyoD–E protein heterodimers (Cole et al., 
2004). Similarly, the p38 kinase stimulates formation of MyoD–E protein 
heterodimers (Lluis et al., 2005). Given that CDO does not seem to have kinase 
activity on its own, it is possible that its influence on MyoD–E heterodimer 
formation is mediated by p38 kinase. 
The binding of MyoD to selected regulatory regions is followed by chromatin 
remodelling. Two domains of MyoD — a histidine- and cysteine-rich region 
(H/C domain) at the N terminus, and a C-terminal region forming an 
amphipathic α helix (helix III domain) are required to mediate chromatin 
modification. 
Binding of MyoD to DNA is required but not sufficient to promote transcription 
(Blais et al., 2005), since co-factors are necessary to its transcriptional activity 
(fig. h). It has been shown that p38 and IGF1-PI3K-AKT pathways proceed as 
two parallel pro-myogenic cascades in myoblasts induced to differentiate (Wu et 
al., 2000). Although both cascades are essential for the activation of the 
myogenic program these two pathways converge at the chromatin level to 
control the assembly of the myogenic transcriptosome, by targeting two 
pharmacologically discrete, yet functional interdependent, events (Serra et al., 
2007). The p38 kinases α/β promote the recruitment of the SWI/SNF complex 
to the chromatin of muscle genes (Simone et al., 2004); IGF1-PI3K-AKT 
pathway controls the engagement of the acetyltransferases p300 and PCAF to 
the muscle regulatory regions by promoting the interaction between MyoD and 
p300. AKT-mediated phosphorylation of the C/H3 region of p300 is one signal-
responsive event that promotes MyoD-p300 interaction. The chromatin-
remodelling SWI–SNF factor interacts with and promotes MyoD activity. The 
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SWI–SNF subunit BAF60 is phosphorylated by the p38 kinase, which can be 
found at myogenic loci (Simone et al., 2004). Indeed, forced activation of the 
p38 kinase pathway by a constitutively active form of MKK6 favours SWI–SNF 
chromatin recruitment, facilitates binding of MyoD and MEF2, and recruitment 
of RNA polymerase II, and anticipates expression of late-activated genes at 
early stages of muscle differentiation (Penn et al., 2004). Pharmacological 
blockade of p38 prevents SWI–SNF recruitment and impedes muscle gene 
expression without affecting either binding of MyoD or recruitment of HATs. 
Given that the p38 kinase activity is necessary for the expression of a restricted 
subset of genes regulated by MyoD, other kinases might regulate recruitment of 
SWI–SNF at different myogenic loci. Alternatively, additional chromatin-
remodelling complexes might be involved in modulating muscle gene 
expression. In addition to its recruitment of chromatin-remodelling complexes, 
MyoD also recruits p300 and PCAF (fig. g). Both MyoD and histones are 
substrates of p300 and pCAF acetyltransferase activities. Initially, p300 
acetylates histones H3 and H4 and, subsequently, pCAF acetylates MyoD, with 
both proteins synergistically activating transcription (Dilworth et al., 2004). 
Therefore, p300 and pCAF execute sequential and distinct but coherent 
functions.  
An indirect mechanism converging on MyoD activation entails removal of the 
inhibition exerted by HDAC4 on MEF2C (Fig. g). The interferon-related 
developmental regulator PC4 associates with MEF2C and, in doing so, displaces 
HDAC4 from MEF2C, thereby indirectly promoting MyoD activity (Micheli et 
al., 2005). 
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Fig h: Schematic representation of MyoD-associated proteins in myobalsts and myotubes. 
 
 
This intricate network of activators and repressors of myogenesis is functional to 
regulate muscle terminal differentiation. The nuclear transcriptional events 
finally drive to the expression and morphological changes occurring during the 
transition from muscle progenitors (myoblasts) to terminally differentiated 
muscle cells (myotubes).  
 
Adult myogenesis and muscle regeneration 
 
Adult skeletal muscle is a stable tissue endowed with a remarkable regenerative 
capacity. After acute injury a large number of new myotubes are formed in only 
a few days after acute muscle damage.  
Whether the muscle injury is inflicted by a direct trauma (i.e., extensive physical 
activity, resistance training) or innate genetic defects, muscle regeneration is 
characterized by two phases: a degenerative phase and a regenerative phase. The 
initial event of muscle degeneration is necrosis of the muscle fibres. This event 
is generally triggered by disruption of the myofibre sarcolemma resulting in 
increased myofibre permeability (Charge and Rudnicki, 2004).  
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The early phase of muscle regeneration post-injury is tipically accompanied by 
the activation of mononucleated cells, principally inflammatory cells and 
myogenic cells. Present reports suggest that factors released by the injured 
muscle activate inflammatory cells residing within the muscle, which in turn 
provide the chemotactic signal to circulating inflammatory cells (Tidball, 1995). 
Muscle degeneration is followed by the activation of a muscle repair process. 
Satellite cells are the main cell type responsible for the muscle repair. In the 
adult, satellite cells are mitotically quiescent and reside in the niche between the 
basal lamina and the sarcolemma of the associated muscle fibres. They are 
readily activated following muscle injury, induced to differentiate and fuse with 
damaged myofibres and are the primary mediators of postnatal muscle growth 
and repair (Wagers and Conboy, 2005). 
What control the transition between quiescence and proliferation, the “activation 
trigger”, remains largely unknown. Traditional master regulators of development 
and growth, including Notch, Wnt and Sonic Hedgehog signalling, have all been 
implicated in the regulation of satellite cell function (Kuang and Rudnicki, 
2008).  
Upon muscle injury, satellite cells first enter the cell cycle and undergo several 
rounds of proliferation. A small subset of the cells, however, exits the cycle and 
relocates in the basal lamina, thereby replenishing the satellite cells pool for 
future regeneration processes. Zammit et al., reported that these two populations 
within the satellite cell compartment are discriminated by their different patterns 
of gene expression (Zammit et al., 2004). Upon activation, Pax7 positive 
satellite cells upregulate Myf5 and MyoD. Most of the Pax7 positive/MyoD 
positive cells undergo several rounds of proliferation. Downregulation of Pax7 
coincides with the activation of the differentiation program, which is initiated by 
MyoD, entails the coordinate expression of the late MRFs, of the cell cycle 
inhibitor p21 and the structural and contractile proteins, and culminates with the 
formation of new myofibers repairing the damaged muscles. A distinct 
population of satellite cells downregulate MyoD, while maintaining the 
expression of Pax7, and remain located in small clusters of cells beneath the 
basal lamina, being responsible for maintaining the pool of cells available for 
further regenerative responses (Zammit et al., 2004)(fig. i).  
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Fig i: Schematic representation of satellite cells activation, proliferation and asymmetric 
division. Adapted from (Zammit et al., 2004). 
 
Notably, the expansion of myogenic cells provides a sufficient source of new 
myonuclei for muscle repair. Activated myogenic cells differentiate and fuse to 
existing damaged fibres for repair or to one another for new myofibre formation. 
Once fusion of myogenic cells is completed, newly formed myofibres increase 
in size and myonuclei move to the periphery of the muscle fibre. Under normal 
conditions, the regenerated muscle is morphologically and functionally 
indistinguishable from undamaged muscle (Charge and Rudnicki, 2004). 
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AIMS OF THE STUDY 
 
During muscle regeneration, progenitor cells are exposed to environmental cues 
that coordinate their activation, proliferation, and differentiation. These cues 
generate a genotoxic rich environment, by stimulating cellular proliferation and 
increasing the intracellular oxidation.  
A previous work in our lab has identified the differentiation checkpoint, as a 
process that, upon DNA damage, transiently inhibits muscle precursor 
differentiation to avoid the formation of genetically unstable differentiated cells. 
We have identified two key molecules in this pathway: the nuclear Abl tyrosine 
kinase and the myogenic transcription factor MyoD, and demonstrated that 
genotoxins activate c-Abl to inhibit differentiation through phosphorylation of 
MyoD.  
Our work is aimed to characterize the differentiation checkpoint in vivo and in 
vitro. In particular we want to further elucidate the impact of DNA damage on 
MyoD function. To this aim we plan to study the molecular events underpinning 
by c-Abl dependent MyoD phosphorylation, including MyoD half life, chromatin 
affinity and protein-protein interactions. We also plan to define whether MyoD 
has a unique role in DNA damage responseof myoblasts or if other muscle bHLH 
proteins can compensate for its absence.  
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MATHERIALS AND METHODS 
 
 
Cell lines, transient transfections and genotoxic treatments 
 
C2C12 and C2C7 myoblasts (Yaffe and Saxel, 1977) were propagated in DMEM 
supplemented with 10% FBS (GM:), differentiation was induced with DMEM 
supplementes with 2% horse serum (DM). 
Human Fibroblasts (kindly provided by Marco Crescenzi), 10T1/2 fibroblasts, 
HEK 293, HEK293 phoenix, NIH 3T3 cells were propagated in DMEM 
supplemented with 10% FBS. 
Transient transfections in HEK 293, HEK 293 phoenix and NIH 3T3 were 
performed using FuGene6 (Roche), in C2C12 using Lipofectamine 2000, 
(Invitrogen) following manufacturer conditions.  
To induced DNA damage cells were treated for 15 hours in growing conditions 
with the following drugs: Doxorubicin 0,4 µM, MMS 75µM, Etoposide 0,5 µM 
50 µM H2O2. For comet assay acute treatment with doxorubicin 3 µM for 1 hour, 
was used 
 
 
Plasmids and mutagenesis 
 
The following plasmids were used: pcDNA3-HA-MyoD-WT, pcDNA3-HA-
MyoD-Y30F (Puri et al., 2002), pcDNA3-HA-Myf5-WT, pcDNA3-Myc-myoD-
WT (kindly provided by Vittorio Sartorelli). 
pcDNA3-HA-Myf5-WT was used as template for the generation of pcDNA3-
HA-Myf5-S19P through direct mutagenesis (QuikChange II site-directed 
mutagenesis kit- Stratagene). The following primers were used for the 
mutagenesis: 
Myf5 S19P fwd: CTTCTATGAAGGCCCCTGTATCCC 
Myf5 S19P rev: GGGATACAGGGGCCTTCATAGAAG  
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Satellite cells isolation and culture conditions  
 
Single muscle fibers with associated satellite cells were isolated as described 
(Rosenblatt et al., 1996). Briefly, the hind limb muscles were digested with 
collagenase and single myofibers were plated on matrigel (Sigma, 1mg/ml ECM 
gel) coated dishes in GM1 (DMEM supplemented with 10% horse serum 
(Gibco), 0.5% chick embryo extract (MP biomedicals) and penicillin–
streptomycin (Gibco) at 37°C. 3 days later the medium was replaced with 
proliferation medium (GM2 - 20% FBS, 10% horse serum, 1% chick embryo 
extract in DMEM) to promote proliferation of detached cells (delaminated 
satellite cells). After 4-5 days the cells were allowed to differentiate replacing the 
medium with differentiation medium (DM - 2% HS and 0.5% chick embryo 
extract in DMEM).  
 
 
Adenoviral infections 
 
cDNA for MyoD and the mutant MyoDY30F were cloned into pAdShuttle-CMV 
to create pShuttle-MKK6EE. Replication-deficient adenovirus expressing MyoD 
wt and Y30F from the CMV promoter was made by homologous recombination 
of pShuttle-MyoD wt/Y30F with pAdEasy in E.Coli BJ5183 generating 
pAdMyoD wt and pAdMyoDY30F. The virus was multiplied by transfection of 
293 packaging cells.  
Adeno-GFP control and Adeno-GFP-CRE were kindly provided by Vittorio 
Sartorelli. 
NIH 3T3 and satellite cells were infected with adenovirus-containing 
supernatants for 1 hour in serum free medium and then placed in growth 
medium. 
 
 
Retroviral infection 
 
ShMyoD and ShCntr (see below for sequences) annealed oligos were subcloned 
into a pSuper-retro vector according to Oligoengine psuper manual and 
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transfected into Phoenix-Eco cells to generate retrovirus. Virus-containing 
supernatant was added on C2C12 or NIH 3T3 cells in growing conditions for 12 
hours in the presence of 8 µg/ml of polybrene (Sigma). Cells were selected in 
puromicin 1ug/ml for 10 days and then efficiency of downregulation was tested. 
 
ShMyoD :  
GATCCCCACACAGCCGCACTCTTCCCTGGCCTGGATTCAAGAGATCCA
GGCCAGGGAAGAGTGCGGCTGTGTTTTTTC 
 
ShCntr: 
GATCCCCCATTGCTATAGAGGCAGATTTCAAGAGAATCTGCCTCTATA
AGCAAT TTTTTC (sequence adapted from (Maehara et al., 2005)) 
 
 
Immunofluorescence and histology 
 
Satellite cells and C2C12 cells were fixed with Methanol/acetone (1:1) for 10 
minutes and permeabilized with 0,5% Triton/PBS. Immunostaining with anti-γ-
H2AX and MyHC (MF20) (developmental studies Hybridoma bank) was 
performed 1hour at room temperature and cy2 or cy3 conjugated secondary 
antibodies were then used. 
Quadriceps muscles were cut transversally, fixed in 4% PFA for 20 minutes and 
permeabilised with 100% methanol for 6 minutes at -20 C. Inmunostaining with 
anti-γ-H2AX (Upstate) and phospho-serin 1981 ATM (Rockland) was performed 
overnight at 4 C after antigen retrieval with 100 mM sodium citrate and blocking 
first with a solution containing 4% BSA in PBS and then with anti-mouse 
AffiniPure Fab fragment (Jackson, 1:100) to avoid unspecific binding. Cy2-
conjugated anti-rabbit and Cy3- conjugate anti-mouse (Jackson) were used as 
secondary antibodies. Nuclei were visualized by counterstaining with DAPI. 
Embryos were dissected in PBS, fixed in 4% paraformaldehyde for 10 minutes, 
rinsed three times in PBS and stained in X-gal solution (1 mg/ml 5-bromo-4-
chloro-3- indolyl-b-D-galactosidase, 5 mM K4Fe(CN),6 5 mM K3Fe(CN),6 
0.02% NP-40, 2 mM MgCl2 in PBS) at 37°C overnight. X-gal-stained embryos 
were examined as whole mounts or after cryostat sectioning into 10 µm sections, 
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as described previously (Kelly et al., 1995) Adjacent sections were stained with 
eosin. 
 
 
Western blot  
 
The levels of endogenous MyoD (Santa Cruz, SC-760), MyHC (MF20, DSHB) 
and tubulin (Thermo Fisher, MS581P1) were detected by western blot analysis 
on total cell extracts after lysis in 50mM Tris-HCl (pH 8.0), 125 mM NaCl, 
1mM DTT, 5mM MgCl2, 1mM EDTA, 10% glycerol, and 0.1% NP-40 
supplemented with 1mM PMSF and protease inhibitor mix. The extracts were 
resolved in SDS-polyacrilamide gels and transferred to nitrocellulose membranes 
(Hybond, Amersham). 
Anti phospho Nbs1 (serine 343) (Cell Signaling 3001S), anti-p62 (Santa Cruz 
SC-25329), anti MyoD (SC-760) and anti phospho tyrosine (4G10 Millipore) 
were used to detect proteins after co-immunoprecipitation of nuclear extracts. 
Secondary antibodies were revealed with the ECL (Amersham) 
chemiluminiscence kit.  
 
 
RNA extraction and RT-PCR 
 
Total RNA was extracted with Trizol (Invitrogen), according manufacturer 
instructions. 0,5-1 µg of RNA were retrotranscribed using the Taqman reverse 
transcription kit (Applied Biosystems). Real time quantitative PCR was 
performed to analyse relative gene expression levels using SYBR Green Master 
mix (Applied Biosystems) and following manufacturer indications. Primers 
sequences are as follow: 
MyoD:  
Fwr:CGCGCTCCAACTGCTCTGATGG 
Rev:CTCGACACAGCCGCACTCTTCC 
 
Myogenin: 
Fwd:GGCTCAAGAAAGTGAATGAGGC 
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Rev:CGATGGACGTAAGGGAGTGC 
 
MCK:  
Fwd:AGTCCTACACGGTCTTCAAGG 
Rev:AGGAAGTGGTCATCAATGAGC 
 
GAPDH universal: 
Fwd:  CACCATCTTCCAGGAGCGAG 
Rev: CCTTCTCCATGGTGGTGAAGAC 
 
 
Chromatin inmunoprecipitation (ChIP) and Re-ChIP 
 
ChIP assay on C2C12 cells was performed as previously described (Simone et 
al., 2004).  
In the ReChIP, after the firts ChIP the samples are eluted with 10mM DTT at 
37C and then re-used for the second ChIP. A fraction is saved after the first 
ChIP. The following antibodies were used: anti-acetylated histone 3 (Upstate), 
MyoD (Santa Cruz SC-760), anti phospho Nbs1 (serine 343) (Cell Signaling 
3001S). Normal rabbit IgG (Santa Cruz, SC-2027) or anti-E1A (Santa Cruz, SC-
25) antibody were used as a control. Real time PCR was performed on input 
samples and equivalent amounts of inmunoprecipitated material using the SYBR 
Green Master Mix (Applied Biosystems). Relative recruitment is calculated as 
the amount of amplified DNA normalized to input and relative to values obtained 
after normal rabbit IgG inmunoprecipitation, which were set as the background 
(one unit).  
Primers used were as follows: 
 
Myogenin promoter: 
 
Fwd:TGGCTATATTTATCTCTGGGTTCATG 
Rev:GCTCCCGCAGCCCCT 
 
MCK enhancer : 
 
Fwd: AGGGATGAGAGCAGCCACTA 
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Rev: CAGCCACATGTCTGGGTTAAT 
 
IgH enhancer: 
 
Fwd: GCCGATCAGAACCAGAACACCTGC 
Rev: TGGTGGGGCTGGACAGAGTGTTTC 
 
 
Co-Immunoprecipitation 
 
Nuclear extract were prepared as described in ChIP protocol (Simone et al., 
2004). Nuclear extract were pre-cleared with protein A/G beads and then 
incubated for 3 hour with the antibody and an additional hour with protein A/G. 
Immuno-complexes were eluted in 2x Laemmli buffer, separated by SDS-PAGE 
and visualized by western blot. 
Anti-HA (Santa Cruz, SC-805), anti-myc (Santa Cruz, SC-789) and anti-MyoD 
were used. 
 
 
Colony formation 
 
C2C12 cells stably expressing ShCntr and ShMyoD were plated at low density 
(300 cells in a 3 cm dish). After 15 hours of genotoxic treatment (doxorubicin 0,4 
uM and MMS 90uM) cells were wash and fresh medium was added. Medium 
were replaced every two days. After 15 days cells were washed in PBS and 
stained with Giemsa solution. 
 
 
Comet Assay 
 
Cells were collected after trypsinization, rinsed once in PBS and resuspended in 
0,5% Low Melting Agaorose (Sigma) (w/v) in PBS. the suspension is spotted on 
agarose-covered slides. After solidification cell lysis is performed for 15 hours in 
a 2.5M NaCl 0.1M EDTA, 10mM tris-HCl, 10% DMSO v/v, 1% Triton, ph 10 
buffer. Then slides are subjected to electrophoretic run (25V/0.280mA) in 
Material and Methods 
 52 
electophoresis buffer (0,05% 200mM EDTA, 0,3% 10N NaOH) for 30 minutes.  
Slides are finally washed and fixed in ethanol 70% for 10 minuti at 4°C. EtBr 12 
mg/µl is used to stain DNA. Images were acquired with a Nikon fluorescnce 
microscope (reslution 1280x1024 pixel). Comets lenght and intensity was 
calculated with Cometscore v1.5 (TriTek). Tail moment represented is the 
mean value of 100 comets. Damaged population correspond to all the cells 
having a tail comet greater than control.  
 
 
Cytofluorimetric analysis 
 
For cell cycle analysis, C2C7 skeletal muscle cells were treated in GM 24 hrs 
with different DNA damaging agents and then shifted in DM for 24 hrs. Cells 
were collected and than stained for 30 minutes at 37C with a solution containing 
propidium iodide at 100 mg/ml, RNase at 200 mg/ml, and 0.2% Triton X-100 
and analyzed with an EPICS XL cytofluorimeter (Coulter). 
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RESULTS 
 
 
Differentiation checkpoint is efficiently executed in myogenic precursors 
arrested both in G1 and G2 phase of the cell cycle.  
 
Our previous work identified c-Abl kinase as the effector of the molecular 
pathway underlying the differentiation checkpoint (Puri et al., 2002). MyoD is 
phosphorylated by DNA damage activated c-Abl and this evens blocks MyoD 
transcriptional activity upon muscle differentiation induction.  
In order to study the ability of different genotoxic agents to affect the cell cycle 
and to induce the differentiation checkpoint, we performed a cytofluorimetric 
and immunofluorescence analysis on C2C12 mouse cell line treated in growth 
medium (GM) with the following DNA damaging agents: the topoisomerase II 
inhibitor etoposide (Eto), the DNA methylating agent methyl methane sulfonate 
(MMS), and the topoisomerase II inhibitor and oxidating agent doxorubicin 
(Doxo), then exposed to differentiation medium (DM). 
The analysis of the cell cycle profile led us to cluster the different DNA 
damaging agents in two main classes by virtue of their ability to affect the cell 
cycle. Doxorubicin, and etoposide impose a G2 cell cycle arrest while MMS 
cause a G1 block.  This indicates two different differentiation checkpoints 
modalities.  
In Fig. 1 we show that the differentiation checkpoint occurs when cells arrest the 
cell cycle both in the G1 phase, which is compatible with the differentiation 
induction, and in the G2 phase, in which MyoD is normally excluded from 
chromatin (Batonnet-Pichon et al., 2006) (fig 1). 
 
 
Results 
 54 
 
 
Fig 1: Immunofluorescence and FACS analysis on C2C12 muscle cell line. C2C12 were treated 
with indicated genotoxic agents for 15 hours and then shifter in differentiation medium. Cell 
were collected for FACS analysis after 24 hours or fixed with methanol/acetone for 
immunofluorescence after 48 hours of differentiation. Dapi was used to mark nuclei, MyHC was 
used as differentiation marker.  
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Primary satellite cells undergo c-Abl dependent differentiation checkpoint 
 
We then tested the ability of primary muscle cells to undergo differentiation 
checkpoint. Satellite cells can be efficiently obtained from mice and cultured in 
vitro. After single fibres isolation satellite cells delamination, proliferation, and 
differentiation can be induced by culturing them in specific media. Satellite cells 
obtained from a 6 weeks wt mouse were exposed to doxorubicin treatment. As 
shown in fig 2 also satellite cells are able to induce the differentiation 
checkpoint, upon genotoxic treatment, as previously demonstrated for C2C12 
muscle cell line,. 
  
 
 
 
Fig 2: Single fibres were isolated from a wt C57Bl6 mouse. After delamination, satellite cells 
were treated with doxorubicin for 15 hours and then shifted in differentiation medium for 48 hrs. 
Staining with anti γ-H2AX and MyHC was performed after methanol/acetone fixation. Dapi was 
used as nuclear staining.  
 
 
We further explored the role of c-Abl in the differentiation checkpoint induction 
in satellite cells. Since Abl1 knockout causes embryonic and neonatal lethality 
(Schwartzberg et al., 1991; Tybulewicz et al., 1991), we use satellite cells, 
derived form single fibres isolated from a c-Ablfl/fl mouse. In this system c-Abl 
can be efficiently excided upon infection of a CRE recombinase. After fibres 
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isolation and satellite cells delamination, cells were infected with adenovirus-
GFP-control (Ad-GFP CNTR) or with adenovirus-GFP-CRE (Ad-GFP CRE). 
As shown in fig 3, ablation of c-Abl in satellite cells, by the infected CRE 
recombinase, renders satellite cells insensitive to genotoxic treatment with 
doxorubicin. This result validates in primary satellite cells our model of 
differentiation checkpoint and confirms that c-Abl is a key effector of the 
differentiation checkpoint, since both myogenic converted fibroblasts (Puri et 
al., 2002) and primary satellite cells ignor the differentiation checkpoint in 
absence of c-Abl. 
 
 
 
Fig 3: Single fibres were isolate from a c-Abl fl/fl mouse. After delamination, satellite cells were 
infected with adenovirus-GFP-control or with adenovirus-GFP-CRE. 24 hours after infection 
cells were treated with doxorubicin for 15 hours and then shifted in differentiation medium for 
48 hours. After fixation, cells were stained for MyHC and nuclei were stained with Dapi. 
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MyoD is required for differentiation checkpoint induction 
 
To evaluate whether MyoD was required for the correct execution of the 
differentiation checkpoint, we generate two different C2C12 cell lines, stably 
expressing ShMyoD or ShCntr. We confirmed MyoD knock down through real 
time quantitative PCR and western blot analysis (Fig. 4). We treated both cell 
lines with mytomycin C and MMS and shifted them into differentiation medium 
for 48h. Untreated cells efficiently undergo cell differentiation even when MyoD 
was knocked down. Of note, basal muscle differentiation is not affected by 
MyoD knock-down, since Myf5 (the other early MRF having redundant 
function), is able to act redundantly and drive differentiation process. ShCntr 
infected cells treated with genotoxic drugs failed to differentiate, whereas MyoD 
down regulation was sufficient to bypass differentiation checkpoint (Fig 5).  
 
 
 
Fig. 4: C2C12 cells were infected with pSuper-retro-ShCntr or pSuper-retro-ShMyoD and then 
selected with puromicin. RNA was extracted from non infected cell (NI) e the two stable cell 
lines, retrotranscribed, and amplified with specific MyoD primers in real time PCR (right panel). 
Western blot using anti MyoD and anti tubulin was performed. 
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Fig 5: C2C12 cells stably expressing ShCntr or ShMyoD were treated with the indicated 
genotoxic drug and shifted to differentiation medium for 48 hrs. Immunoflorescence was 
performed after methanol/acetone fixation. MyHC was used as differentiation marker. DApi was 
used to stain nuclei. In the bottom part are shown the real time PCR showing the efficiency of 
the interference (left) and the differentiation marker MHC after each treatment in shCntr infected 
cells (middle) or shMyoD infected cells (right).  
 
 
 
These data clearly demonstrate that MyoD is required for differentiation 
checkpoint suggesting an active role of this transcription factor during this 
process. 
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c-Abl consensus site discriminates MRFs for the ability to induce 
differentiation checkpoint 
 
During embryonic myogenesis, Myf5 and MyoD drive two spatially distinct 
differentiation programs, the epaxial (early) and hypaxial (late) myogenesis 
respectively (Cossu et al., 1996). The temporal and spatial differences in 
expression do not correspond to functional differences, since both MyoD and 
Myf5 activate myogenesis by redundant mechanisms and conserved domains 
(Rudnicki et al., 1992).  
The fact that MyoD knock-down impaired the execution of the differentiation 
checkpoint, suggested an active role of MyoD in this process, that can’t be 
supplied by the other MRFs.  
An inspection of the aminoacidic sequences of the MRFs, revaled that MyoD is 
the only one with the consensus site for c-Abl phosphorylation (YXXP) (Fig6). 
The other bHLH have the phospho-acceptor tyrosine, but lack the last proline 
that defines the c-Abl consensus site (fig. 6).  
 
 
 
 
Fig 6: Aminoacidic sequence alignment of the four MRFs. The red box shows the c-Abl 
consensus site (YXXP). 
 
 
 
 
Conversion of fibroblasts into myogenic cells by ectopic expression of MyoD 
and Myf5, show that only MyoD-driven myogenesis is sensitive to DNA 
damage, as the myogenic conversion driven by Myf5 was instead resistant to 
mytomicin C (Fig 9). 
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To evaluate whether the c-Abl phosphorylation site is sufficient to discriminate 
MyoD and Myf5 for the ability to activate differentiation checkpoint, we 
generated two different mutants (Fig 7). We substituted MyoD tyrosine 30 with 
phenylalanine (Y30F), and Myf5 serine 19 with proline (S19P). These two point 
mutations destroy the cAbl phosphorylation site on MyoD and generate a novel 
consensus site on Myf5, respectively (fig 7). 
 
 
 
 
Fig 7: Sequence alignment between N-terminal region of the MRF MyoD and Myf5 and 
mutagenesis scheme. 
 
 
We confirmed the functional relevance of these two point mutations by 
analyzing the ability to undergo tyrosine-phosphorylation after genotoxic 
treatment. As shown in fig 8, the levels of p-tyr increase upon DNA damage 
both in MyoD and Myf 5 depending on the presence of the c-Abl consensus site.   
 
 
 
 
Fig 8: 293 cells were transfected with either the wt or the mutated forms of HA-tagged MyoD 
and Myf5. After transfection cells were treated with MMS (150uM) for 2 hours while growing 
in growth medium and nuclear extracts were prepared for immunoprecipitation with anti-HA 
antibody. Immunoprecipitated lysate was analyzed for the expression of MyoD and Myf 5, and 
for their relative tyrosine phosphorylation, using anti-phospho-tyrosine antbody. 
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To explore the ability of the mutant proteins to drive differentiation checkpoint 
we performed fibroblasts myogenic conversion experiments. Accordingly with 
the phosphorylation pattern previously observed after genotoxic treatment, the 
MyoD Y30F substitution renders it resistant to DNA damage- activated 
differentiation checkpoint. On the contrary, Myf5 S19P substitution, in which the 
c-Abl consensus site was created showed a reduced ability to convert fibroblasts 
in response to DNA damage (fig 9). 
 
 
 
Fig 9: Myogenic conversion of mouse fibroblasts with MyoD wt, MyodY30, Myf5 and 
Myf5S19P. Cells were transfected with the indicated plasmid, 24hrs later they were treated or 
not with the genotoxic drug mytomycin C for 12 hrs and then shifted in differentiation medium 
for 48 hrs. Differentiation was detected with anti myosin heavy chain (MyHC) antibody both in 
immunofluorescence and in western blot. Dapi was used to mark nuclei in immunofluorescence. 
Tubulin antibody was used as loading control in western blot. 
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To further confirm these data we performed in vivo experiments, in 
collaboration with Giulio Cossu laboratory, to test the effects of genotoxic 
treatment during embryonic myogenesis. MLC1/3F-nLacZ pregnant mice (Kelly 
et al., 1995) were treated with two consecutive injections of Myt-C. Embryos 
were then collected and analyzed for b-gal staining. Of note MyoD driven 
(hypaxial) but not Myf5 driven (epaxial) myogenesis was inhibited by treatment 
with genotoxic drugs during embryonic development (fig 10). This evidence 
supports the existence of a MyoD dependent differentiation checkpoint during 
developmental myogenesis. 
 
  
 
 
Fig 10: MLC1/3F-nLacZ pregnant mice were treated with a two consecutive injection of Myt-C 
(2 mg/Kg in 0.5 ml of PBS at E8.5 and 4 mg/Kg in 0.5 ml of PBS at E9). Embryos were 
collected 24 h after the first injection (E9.5), X-gal stained and then sectioned. X-Gal, whole 
mount staining reveals the described nuclear staining in myotomes (up left) in control embryo; 
in contrast only the epaxial (dorsal) region of the myotome is stained in MytC treated embryos. 
This is more evident in enlargements (bottom) where the arrow indicated the ventral border of 
the myotome, and in histological sections, counterstained with Eosin (up right).  
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MyoD binds to muscle specific promoters after DNA damage in 
undifferentiated cells 
 
MyoD is the master regulator of muscle differentiation. During differentiation, 
changes in MyoD post-translational modifications and MyoD-associated 
complexes occur to activate muscle specific genes transcription (Sartorelli and 
Caretti, 2005). The finding that MyoD is one essential mediator of the 
differentiation checkpoint prompted us to evaluate the ability of MyoD to be 
recruited on its target sequences upon DNA damage. To this aim we performed 
Chromatin immunoprecipitation (ChIP) experiments. Surprisingly we found 
that, after DNA damage, MyoD is recruited to the muscle genes promoters in 
undifferentiated cells (Fig 11), in which MyoD is typically unable to bind the 
DNA responsive elements (Ebox). This effect was specific for muscle genes 
promoters, since no recruitment of MyoD was observed to IgH enhancer, a 
region containing an Ebox (compared to a not-related antibody). As we never 
observed MyoD protein levels increasing upon DNA damage, these data 
indicate that DNA damage increases the ability of MyoD to bind the DNA Ebox 
responsive elements. However, this binding did not promote transcription of 
target muscle genes (fig. 12). Thus, we speculate that MyoD recruitment to 
Ebox upon DNA damage might reflect still uncharacterized MyoD functions.   
We next evaluated the chromatin modifications induced by MyoD recruitment in 
undifferentiated C2C12 cells. We found that the promoter regions around MyoD 
binding site were hyperacetylated (Fig 11). This suggests a DNA damage 
dependent role for MyoD in chromatin distension, different from muscle-related 
genes transcription (Kim et al., 2009; Morrison and Shen, 2005; van Attikum 
and Gasser, 2005a). 
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Fig 11: ChIP experiment in C2C12 cells. After crosslinking MyoD and acetylated histone H3 
were immunoprecipitated. Purified DNA was amplified for on Myogenin, muscle creatin kinase 
(MCK) and IgH promoter sequences. 
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Fig 12: Relative expression levels of Myogenin and Muscle creatine kinase (MHC) in C2C12. 
After 15hrs of the indicated treatments, cells were starved and RNA was extracted. After retro-
transcription reaction, real time PCR was performed using primers specific for Myogenin, MCK 
and gapdh. Each mRNA level was normalized for the gapdh. 
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DNA damage-induced, c-Abl dependent, MyoD phosphorylation is required 
to recruit MyoD on muscle specific loci 
 
As the differentiation checkpoint activation relies fundamentally on the ability 
of the c-Abl kinase to phosphorylate MyoD, we investigate the ability of the 
MyoD mutant Y30F, which lacks the c-Abl responsive site, to be recruited on 
chromatin upon DNA damage. We performed fibroblast conversion experiments 
infecting NIH3T3 cells with MyoD wt or MyoD Y30F. ChIP experiment 
showed that upon exposure to genotoxic agents, MyoD Y30F fails to be 
recruited on promoter of muscle genes, while MyoD wild type was bound on the 
chromatin of these genes (Fig 13). These data demonstrate a strong correlation 
between MyoD phosphorylation by DNA damage activated c-Abl kinase, MyoD 
recruitment on chromatin and the execution of functions related to the 
differentiation checkpoint. 
 
 
 
Fig 13: ChIP experiment in NIH-3T3 mouse fibroblasts. Cells were infected with control 
adenovirus, adeno-MyoD wt or Adeno MyoD Y30F. 24 hours after infection were treated, were 
indicated, with doxorubicin 0,4uM for 12 hrs. Anti MyoD antibody was used for the ChIP. 
Purified DNA was amplified with primers specific for Myogenin and muscle creatin kinase 
promoter regions. 
Results 
 67 
MyoD interacts with DNA damage responsive proteins on chromatin. 
 
The data presented in the previous sections prompted our interest toward a 
potential implication of MyoD in DNA damage activated pathways, such as 
lesion recognition and repair.  
We first tested the ability of MyoD to associate with proteins involved in DNA 
damage repair.  
Through co-immunoprecipitation experiments, we analyzed the possibility that 
MyoD could interact with proteins involved in DNA lesion recognition or DNA 
repair mechanisms.  One of the first proteins involved in DNA damage response 
is NBS1, which is activated by ATM through a phosphorylation on serine 343. 
Activated-p-NBS1 associates with DNA lesions and mediates initiation of DNA 
repair process. Upon DNA damage MyoD is able to co-immunoprecipitate with 
activated-NBS1 (fig. 14). 
In contrast, we could not detect important transcriptional co-activators, such as 
the SWI/SNF component Brg1, which typically confers on MyoD the ability to 
activate transcription (data not shown). 
An important complex that promotes both transcription and repair is TFIIH. We 
found an association of the TFIIH subunit p62 and MyoD only after DNA 
damage (fig. 14). 
All these data suggest that in undifferentiated cells, upon DNA damage, MyoD 
can enter a novel multi-protein complex, together with proteins of DNA damage 
response pathway. 
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Fig 14: Co-IP experiments in C2C12 cells and 293 cells. C2C12 were treated or not with 0,4uM 
doxorubicin for 12 hours and then nuclear extracts were collected. Anti MyoD antibody was 
used for immunoprecipitation. Anti ser 343 NBS1, anti TFIIH p62 anti anti MyoD were used for 
western blot detection. 293 cells were transfected with a myc-empty vector or with myc-MyoD. 
24 hours after transfection were treated or not with 0,4uM doxorubicin for 12 hours. An anti 
myc antibody was used for immunoprecipitation. Anti MyoD, anti ser 343 NBS1, anti E47 and 
anti p300 were used for western blot detection.  
 
 
 
The ability of MyoD to bind active-NBS1 after DNA damage prompted us to 
investigate the possibility that this interaction takes place on the chromatin. 
We performed re-ChIP experiments to test whether MyoD and Nbs1 co-localize 
in the same DNA regions. Since DNA damage occurs randomly throughout the 
genome, the immuno-purified DNA was quantified with spectrophotometer 
(nanodrop) rather than amplified for a specific sequence. In particular we 
investigated whether MyoD was recruited on DNA lesions through NBS1, or 
instead NBS1 was recruited by MyoD on muscle specific promoters.  
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The first ChIP fraction demonstrated that both MyoD and phospho-NBS1 are 
recruited to the chromatin of doxorubicin treated cells (Fig 15). The re-ChIP of 
MyoD-bound DNA with anti NBS1 antibody revealed that NBS1 binds 
preferentially to MyoD sites, but not the contrary (Fig 5a).  These data suggest 
that MyoD can shift between two different chromatin-associated complexes, one 
involved in transcription and the other in DNA lesion recognition or repair.  
 
 
 
 
Fig. 15: ReChIP experiment on C2C12 cells after doxorubicin treatment. Crosslinked chromatin 
was extracted from C2C12 cells in growing medium, treated or not with 0,4uM doxorubicin. 
Half of the sample was immunoprecipitated with anti MyoD antibody and then re-Chipped with 
anti Nbs1. The other half was immunoprecipitated with anti Nbs1 antibody and then re-Chipped 
with anti MyoD. Fractions were taken at the beginning (pre-immune input), after the first ChIP 
and at the end. 
 
 
Results 
 70 
cAbl-MyoD axis is required for DNA damage repair and cell survival under 
genotoxic stress. 
 
To evaluate the functional significance of our results we tested the ability of 
myoblasts in which MyoD was knocked down to efficiently repair and survive 
under genotoxic treatment. 
To this aim C2C12 were infected with pSuper-retro-ShCntr or pSuper-retro-
ShMyoD and then selected with puromicin (fig. 16). Colony formation assay 
showed that cells with reduced amount of MyoD were more sensitive to DNA 
damage induced by doxorubicin and MMS treatment (fig 17).  
 
 
 
Fig 16: C2C12 were infected with retroviral vector carrying a shCntr or ShMyoD sequence and 
then selected in puromicin. MyoD protein levels were analyzed in western blot. Densitometry of 
western blot is shown in the right panel. 
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Fig 17: C2C12 stably expressing ShCntr or ShMyoD were plated at low density and then treated 
with the indicated drugs for 15 hours. After 10 days colonies formed were counted, upon Giemsa 
staning. 
 
 
To test whether MyoD was invoved in DNA damage repair, we use comet assay 
(Ostling and Johanson, 1984) the most suitable technique to directly analyze 
DNA lesions. Comet assay entail elecrophoresis of agarose-embedded cells after 
denaturation. During electrophoresis, un-damaged DNA runs as a compact spot, 
while fragmented DNA runs as a smear, depending on the relative DNA fragment 
lenght to form a “comet”. The evaluation of length and intensity of the comet 
(tail moment) are a direct measure of DNA lesions. The progressive shortening 
of the comet is a measure of DNA lesions repair. 
When performing comet assay, we show that myobasts with lower levels of 
MyoD, display a significantly reduced ability to repair DNA lesions (fig. 18).  
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Fig 18: C2C12 ShCntr and ShMyoD were treated with doxorubicin. 1hour after treatment cells 
were collected at different times, as indicated in the graph. Comet assay was performed as 
described in matherial and methods. Tail moment (top) and percentage of damaged cells 
(bottom) at each time point are represented in the graphs. 
 
 
 
Of note a strong impairment in DNA damage repair was observed in primary 
human fibroblasts converted with MyoD Y30F compared to MyoD wt (fig. 19). 
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Fig 19: Human primary fibroblasts were converted to myogenic lineage through adenoviral 
infection with Adeno-MyoD wt or Adeno-MyoD Y30F. 30 hours after infection cells were 
treated with doxorubicin. 1hour after treatment cells were collected at different times, as 
indicated in the graph. Comet assay was performed as described in matherial and methods. Tail 
moment at each time point is represented in the graphs. 
 
 
 
These data demonstrate the biological importance of the presence of MyoD and 
in particular of a functional cAbl-MyoD signalling in DNA damage response. 
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DNA damage response pathways are activated during muscle regeneration 
 
During adult life myofibres regeneration occurs after physiologic (physical 
activity) or pathologic (muscle dystrophies) injury and is realized through 
activation, proliferation and differentiation of muscle stem cells, called satellite 
cells (Le Grand and Rudnicki, 2007). The regeneration process entails the 
necrosis of the damaged tissue, inflammation and cytokines release (Palacios 
and Puri, 2006). This environment, although being the prerequisite for an 
efficient activation of satellite cells, could represent a source of DNA damage. 
We analyzed whether during muscle regeneration DNA damage pathways are 
activated. We compared wt mice and MDX mice (Bulfield et al., 1984), mouse 
model of muscular dystrophy, in which regeneration is highly activated, as 
demonstrated form the high number of centre-nucleated fibres (fig 20). We 
found that in MDX mice, activated satellite cells show a strong 
immunoreactivity for marker of DNA lesions, such as γ-H2AX, or markers of 
activated DNA damage response pathways, such as p-ATM. 
These data demonstrate the existence of a DNA damage rich environment 
during muscle regeneration and the ability of muscle cell to sense and react to 
this endogenous genotoxic insults. This result also strongly supports the idea 
that the differentiation checkpoint could play an important role in vivo.  
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Fig 20: Inmunofluorescence staining using antibodies against γ-H2AX (green), phospho-
ser1981-ATM (red) and counterstained for DAPI (blue), on transversal quadriceps sections from 
six weeks old wt or mdx mice. The bottom panel presents the merge with the phase contrast. 
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DISCUSSION 
 
 
Studies performed in the last few years have highlighted key differences in the 
response to DNA damage in undifferentiated vs terminally differentiated cells 
(reviewed in Simonatto et al., 2007). Terminally differentiated cells 
preferentially use the transcription-coupled repair (TCR), thereby safeguarding 
only the genes that are transcribed, while undifferentiated cells tend repair the 
whole genome by mechanism of global genome repair (GGR). Our work focuses 
on the response to DNA damage in muscle precursor cells that are committed to 
differentiation. This work was inspired by the discovery that DNA damage 
triggers a differentiation checkpoint, which holds the transcription of tissue 
specific genes until the DNA lesion has been repaired. An impaired 
differentiation checkpoint might therefore lead to the formation of genetically 
unstable differentiated cells, which can trigger the senescence program and can 
be associated to defective functions. Thus, elucidating the molecular 
underpinnings of the differentiation checkpoint might reveal novel insight into 
the relationship between senescence in terminally differentiated tissues and their 
functional decline associated with aging. 
 
 
Differentiation checkpoints induced by different genotoxic agents in 
undifferentiated muscle precursor cells are superimposed to DNA damage-
activated cell cycle checkpoints. 
 
The differentiation checkpoint was first described in 2002 in muscle cell lines 
and in MyoD-converted fibroblasts (Puri et al., 2002).  
In the present work we have identified two major cell cycle boundaries in which 
the differentiation checkpoint can be activated – the G1 phase and in G2/M 
transition of the cell cycle (fig. 1).  
The differentiation checkpoint that occurs during G1 faces the challenge of 
overcoming the spontaneous tendency of myoblasts to differentiate in this phase 
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of the cell cycle. Our data show that in myoblasts that were arrested in G1 upon 
exposure to genotoxic agents, such as MMS, MyoD phosphorylation by DNA 
damage activated cAbl inhibits transcriptional activity of DNA bound MyoD 
(Puri et al., 2002). By contrast, the G2/M phase of the cell cycle is not permissive 
for muscle differentiation, since during this transition, MyoD is downregulated 
and excluded form the chromatin (Batonnet-Pichon et al., 2006). In this respect, 
the inhibition of MyoD by G2 genotoxic agents appears a direct consequence of 
the G2 cell cycle checkpoint.  
Interestingly, MyoD tyrosine phosphorylation was detected also in response to 
genotoxic agents that activate the G2 differentiation checkpoint (Puri et al., 
2002), in which MyoD activity is inherently inhibited by the lack of binding to 
EBoxes. This finding suggests that cAbl-mediated phosphorylation regulates 
MyoD functions that extend beyond the activation of muscle gene transcription.  
 
 
The c-Abl -MyoD pathway in regulation of gene transcription and repair in 
muscle cells. 
 
In the present study we also show that the differentiation checkpoint operates in 
primary satellite cells derived from single fibres (fig. 2). In these cells, as 
previously seen for C2C12 cell line (Puri et al., 2002), differentiation checkpoint 
is dependent on the presence of c-Abl kinase. Indeed genetic depletion of c-Abl 
in primary satellite cells derived from c-Abl-lox mice is sufficient to bypass 
differentiation checkpoint (fig. 3).  
We previously mapped the c-Abl phosphorylation site on MyoD tyrosine 30 
(Puri et al., 2002), identifying a c-Abl-MyoD axis required for differentiation 
checkpoint activation. We used RNA interference for MyoD to show its 
requirement for differentiation checkpoint activation (fig. 4). Indeed down-
regulation of MyoD led to an impairment of differentiation checkpoint (fig. 5), 
suggesting that the differentiation checkpoint is not a simple inhibition of MyoD 
transcriptional activity. This result implies indeed that MyoD has an active role 
in the differentiation checkpoint program, and suggest that this function cannot 
be replicated by other muscle bHLH proteins present in myoblasts (e.g. Myf5). 
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c-Abl consensus discriminates different functions of MRFs 
 
MyoD is the only MRF having a consensus site for c-Abl kinase (fig. 6). During 
embryo muscle development, Myf5 and MyoD have distinct termporal and 
spatial pattern. However, null mutations in either Myf5 or MyoD result in 
apparently normal muscle development, demonstrating a degree of genetic 
redundancy in the MyoD family (reviewed in Berkes and Tapscott, 2005).  
We show that the presence of the c-Abl site correlates with the phosphorylation 
of MyoD after DNA damage (fig. 8) and is essential for the activation of the 
differentiation checkpoint (fig.9). Of note these features are recapitulated by 
Myf5 S19P in which the c-Abl site, absent in the wt protein, is artificially 
created, and completely abolished when the c-Abl phosphorylation site is 
disrupted in the MyoD Y30F mutant (fig.7). These results therefore identify a 
functional difference between the two early MRFs, MyoD and Myf5, in the 
ability to transduce the DNA-damage activated c-Abl signal and activate 
differentiation checkpoint. Accordingly, in vivo data show that during 
somitogenesis only MyoD driven myogenesis (hypaxial), but not Myf5 driven 
myogenesis (epaxial) is inhibited in response to DNA damage, further confirm 
our data obtained in cell cultures. The cAbl phosphorylation motif found in 
MyoD sequence is evolutionary conserved among vertebrate, therefore 
highlighting the importance of MyoD phosphorylation in regulating the response 
of muscle progenitors to DNA damaging cues.   
Many studies failed to identify functional differences between MyoD and Myf5 
that can account for their different temporal and spatial distribution during 
skeletal myogenesis. Indeed MyoD and Myf5 appear to activate myogenesis by 
redundant mechanisms and conserved domains (Gerber et al., 1997; Puri and 
Sartorelli, 2000). The ability of MyoD, but not Myf5, to respond to DNA 
damage provides the first molecular rationale to functionally discriminate these 
two MRFs. This rationale resides in the presence of a DNA damage-responsive 
motif that enables MyoD, but not Myf5, to undergo transient phosphorylation 
and functional inactivation in response to genotoxic insults.  
 
Discussion 
 79 
Different response to DNA damage activated signalling in epaxial vs 
hypaxial myogenesis 
 
This difference suggests the existence of a developmental mechanism that 
diversifies epaxial and hypaxial myogenesis during somitogenesis.  
Since epaxial muscles are the first to develop, tolerance to the DNA damage-
activated differentiation checkpoint would ensure acquisition of early motility, 
required for embryo survival, in spite of environmental signals that could 
otherwise block myogenesis. Conversely, MyoD-dependent hypaxial 
myogenesis, which gives rise to the large majority of skeletal muscles in the 
adult body of amniotes is regulated by the differentiation checkpoint, which 
relies on the transient tyrosine phosphorylation of MyoD in response to 
genotoxic stimuli.  
According to this hypothesis, sequence diversification in functional homologues 
of myogenic bHLH proteins during their evolution could be interpreted as the 
result of a pressure that confers the ability to respond to or ignore environmental 
stress. Interestingly, the MyoD sequence in all vertebrates shows the presence of 
the DNA damage responsive motif; however, this sequence is not present in any 
of the invertebrate MyoD cloned thus far, including Amphyoxus, Ascidiae, 
Echinoderm and C. elegans. This observation suggests that in invertebrates, in 
which most of the myogenesis is driven by a single bHLH, the DNA damage-
activated differentiation checkpoint must be ignored, as it might delay the 
formation of muscles. Thus, the differentiation checkpoint may represent an 
evolutionary evolved mechanism that ensures genome stability of hypaxial 
muscles in vertebrates.  
 
 
Upon DNA damage MyoD is recruited to muscle genes promoters, in a c-Abl 
dependent way 
 
MyoD is the master gene of muscle differentiation. Pro-differentiation stimuli 
activate pathways converging at the chromatin level to coordinate the assembly 
of the myogenic transcriptosome on MyoD (Serra et al., 2007; Simone et al., 
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2004; Wu et al., 2000). MyoD is present in myoblast as transcriptional inactive 
homodimer. Upon differentiation induction, p38 and IGF1-PI3K-AKT pathways 
target on MyoD co-activators that cause MyoD association with E proteins 
(forming the transcriptional proficient heterodimer) and modification of 
chromatin and MyoD itself, leading to transcription activation (Sartorelli and 
Caretti, 2005). 
The differentiation checkpoint is induced only when progenitor cells are exposed 
to genotoxic drugs, while DNA damage does not reverse the differentiation 
program once it is established (Puri et al., 2002), suggesting that MyoD can have 
a DNA damage induced function only in myoblasts.  
In this work we demonstrate that, upon DNA damage, MyoD is strongly 
recruited to muscle gene promoters in myoblasts (fig. 11), without promoting 
their transcription (fig. 12), although chromatin modifications permissive for 
transcription are induced (fig. 11). Of note in myoblasts, MyoD forms 
homodimers that have no transcriptional activity, whose function is completely 
unknown (Sartorelli and Caretti, 2005). 
Blais et al. identified, through ChIP-on-Chip experiments, approximately 200 
genes bound by MyoD and/or myogenin and MEF2 (Blais et al., 2005). Of its 
approximately 100 target genes, MyoD bound to half in undifferentiated 
myoblasts and the other half in differentiated myotubes. Several targets bound by 
MyoD were activated neither in myoblasts nor in myotubes. Others were 
activated only in either myoblasts or myotubes. This finding suggest that in 
myoblasts MyoD (possibly in the form of homodimer) plays an yet unknown 
role.  
The data showing MyoD recruitment and hyperacetylation of muscle promoters 
upon DNA damage, indicate that MyoD has two completely different functions, 
one in DNA damage response and the other in muscle differentiation genes 
transcription. These two functions appear to correlate with two mutually 
exclusive MyoD-associated complexes in myoblasts and myotubes, respectively. 
Consistently, the cAbl phosphorylation-resistant MyoD Y30F mutant retains a 
proficient transcriptional activity and ability to induce the differentiation 
program, but does not respond to DNA damage activated signalling. 
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MyoD interaction with DNA damage responsive proteins is implicated in 
cell survival and DNA repair upon genotoxic treatments 
 
Upon differentiation stimuli, pathways are activated to coordinate the assembly 
of the myogenic transcriptosome on MyoD (Serra et al., 2007; Simone et al., 
2004; Wu et al., 2000). 
In this work we show that in myoblasts treated with genotoxic drugs, MyoD 
associates with proteins typically involved in DNA lesions recognition and 
repair, such as phosphorylated NBS1 and p62 subunit of TFIIH (fig. 14), rather 
than it typical transcriptosome. 
We demonstrate that the association of MyoD and NBS1 occurs on the 
chromatin. Moreover ReChiP experiments show that MyoD is able to recruit 
NBS1 on its binding site (fig. 15), rather than the contrary. This finding suggest 
that upon genotoxic treatments, MyoD is able to recruit DNA damage 
responding proteins on its binding sites, conceivably to mediate a specific 
safeguard of its target sequences. 
We also show that MyoD knock-down impairs DNA damage repair in 
myoblasts (fig. 18) and renders them much more sensitive to genotoxic agents, 
since MyoD knock-down cause a decrease in myoblasts survival upon genotoxic 
treatments (fig. 17).  
These results therefore imply a role for MyoD in DNA repair pathways. In 
myoblasts exposed to genotoxic agents MyoD could mediate DNA repair by 
recruiting DNA damage activated proteins by binding to specific sequences. The 
finding that, upon DNA damage, the same sites bound by MyoD are 
hypeacetylated supports this hypothesis. It has been reported indeed that DNA 
damage induces chromatin modification facilitating lesions recognitions and 
repair (Morrison and Shen, 2005; van Attikum and Gasser, 2005a). 
The role of MyoD in DNA damage response in adult muscle cannot be 
extrapolated by available data on MyoD-null mice, as they have never been 
challenged with genotoxic agents. However it should be noted that MyoD-null 
satellite cells are defective in regeneration (Sabourin et al., 1999) and show 
impaired apoptosis (Asakura et al., 2007). Several works have identified a link 
between MyoD and apoptosis induction, since MyoD overexpression induces 
apoptosis, through a p21 dependent mechanism, in cells lacking Rb (Peschiaroli 
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et al., 2002). Blais et al in 2005 performed a ChIP-on-Chip analysis aimed to 
identify MyoD targets in myoblasts and myotubes. It is worth noting that a 
group of genes, whose promoters are bind by MyoD in myoblasts, but not in 
myotubes, contains genes involved in stress response, heat shock, cell 
cycle/growth control and DNA repair/ replication (Blais et al., 2005).  
Results presented in this work, together with data present in literature, strongly 
support an involvement of MyoD in DNA damage response in muscle precursor 
cells. 
 
 
Activation of DNA damage pathways in vivo during adult regeneration. 
 
In adult life muscle regeneration entails the necrosis of the damaged tissue, 
inflammation and cytokines release (Palacios and Puri, 2006). This environment, 
although being the prerequisite for an efficient activation of satellite cells, 
constitutes a source of DNA damage. Oxidative damage is the most frequent 
threat for the genome integrity of regenerating tissues, as it might derive from 
both DNA synthesis and the reactive inflammation in the regenerative 
microenvironment. Thus, the ability of tissue progenitors to properly cope with 
DNA damage might have an impact on the genome integrity of their 
differentiated progenies. 
A pathologic situation in which regeneration is induced at high levels is 
muscular dystophy, whose animal models are MDX mice. We show here that, in 
MDX mice DNA damage pathways are activated (fig. 20). This finding provides 
a strong evidence that DNA damage might occurs in vivo in response to 
regeneration cues. 
Although it is difficult to firmly demonstrate the existence of the differentiation 
checkpoint in vivo and the consequence of its failure, our data that isolated 
satellite cells have the ability to undergo differentiation checkpoint in a cAbl-
dependent manner is a prelude for future in vivo studies (fig. 2 and 3). These 
experiments will test the biological consequence of an impaired activation of the 
DNA damage pathway during adult muscle regeneration, by using cAbl fl/fl 
mice bred with Pax7-CRE mice, to specifically ablate cAbl expression in 
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satellite cells. We postulate that in these mice myofibres bearing unrepaired 
lesions will form. The long term consequences of the presence of unrepaired 
lesions in vivo is largely unknown, although recent studies have shown that 
accumulation of un-repaired lesions can eventually trigger senescence or 
malignant transformation (Bartkova et al., 2006; Di Micco et al., 2006; Kastan 
and Bartek, 2004).  
Another issue of key importance will be the identification of the sequences 
bound by MyoD upon DNA damage. Depending on the ability of MyoD of 
safeguarding the whole genome or only those genes that are important for 
muscle differentiation, we can hypothesize the occurrence of cancer (e.g. 
rhabdomyosarcoma) or progeroid syndromes (e.g. sarcopenia), like happens in 
NER defects affecting only the GGR or the TCR subpathways (Garinis et al., 
2008). 
To this purpose will be of extreme interest to analyze MyoD-/- mice to test 
whether the differentiation checkpoint pathway is active along the lifespan and 
the possible consequences of a decrease on its efficiency. This study would 
contribute to understand the mechanisms leading to a decrease in numbers and 
regenerative potential of satellite cells during lifespan.  
It is worth noting that Chamberlain et al. reported that MDX mice display an 
increased susceptibility to spontaneous rhabdomyosarcoma, compared to wt 
mice (Chamberlain et al., 2007), suggesting that the differentiation checkpoint 
cold be an important mechanism to maintain genome stability in muscle during 
sustained regeneration. 
The nuclear reprogramming occurring among neighbouring nuclei in 
multinucleated cells (Pomerantz and Blau, 2004) suggests that multi-nucleation 
(e.g. in myotubes) might attenuate the effect of the genetic instability introduced 
by sporadic accretion of nuclei bearing un-repaired DNA lesions. Otherwise, the 
effect of these latter can be dominant over the large majority of the nuclei. To 
date, these issues remain unexplored. 
 
Discussion 
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CONCLUSIONS 
 
 
Collectively the results presented here reveal a new function for the muscle 
transcription factor MyoD in DNA damage response. We show that in myoblasts 
exposed to genotoxic agents, MyoD, but not other muscle bHLH transcription 
factors, undergoes c-Abl dependent phosphorylation. Upon DNA damage MyoD 
is recruited to muscle specific promoters and associates with proteins involved in 
DNA damage response rather than transcriptional coactivators. Finally we show 
that MyoD affects DNA repair and cell survival upon genotoxic treatments. 
We therefore propose a model in which c-Abl dependent phosphorylation of 
MyoD is the molecular event that turns MyoD ability to activate transcription of 
muscle genes into a DNA damage repair function.  
This new role of MyoD in DNA damage response would be a novel mechanism 
of DNA repair, tissue specific and transcription factor mediated.  
It is worth noting that master genes of other differentiation systems, such as 
NeuroD1/BETA2 and neurogenin share with MyoD common domains and 
regulation mechanisms. Moreover quite recently Kang et al reported that Oct4, 
the master regulator of stem cells state, is phosphorylated upon DNA damage 
induction and that this event causes its recruitment to specific DNA sequences. 
This suggests the possibility that master genes of a tissue differentiation of a 
differentiation status, would mediate specific DNA repair by shifting their 
function from transcription to repair. 
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